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Abstract
Cells of the monocyte-macrophage lineage play a central role in inflammation and in
the pathogenesis of inflammatory disease states. During inflammatory responses,
these cells are able to recognise and eliminate invading micro-organisms via efficient
phagocytic and cytocidal host defence mechanisms. In addition to this effector role,
monocytes and macrophages can produce a vast array of cytokines and chemokines
which affect the responses of other cells and can influence the progression of
inflammation.
From the moment of extravasation into areas of inflammation, the surrounding
microenvironment has a profound effect on monocytes and macrophages and can
influence the differentiation process that occurs in monocytes within different tissues,
or at different stages of inflammation.
During extravasation, monocytes and macrophages encounter elements of the
extracellular environment, normally arranged in a stable structure of proteins,
glycoproteins, and proteoglycans, known as the extracellular matrix. At sites of
injury, this stable structure is simulated by a provisional matrix, which is formed as a
result of vascular coagulation, and is one of the first influences on elicited cells as
they migrate into the inflammatory site.
This study shows that hyaluronan, which is a ubiquitous component of the
extracellular matrix, and a major component of the provisional matrix , has a pro¬
inflammatory effect on monocytes and macrophages. This effect was not observed
with other ECM components, including fibronectin, vitronectin, collagen I and
heparan sulphate, which is structurally related to hyaluronan.
In this thesis, the pro-inflammatory effects on both monocytes and monocyte-derived
macrophages were examined. The effects of hyaluronan on monocytes were found to
include the production of cytokines, specifically TNFa and IL-1 (3. Monocyte-
derived macrophages also responded to hyaluronan with the production of TNFa.
This response involved the hyaluronan receptor CD44, the expression ofwhich is
increased upon in vitro maturation.
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These pro-inflammatory effects of hyaluronan may have serious implications for the
pathogenesis ofmany inflammatory disease states. The adult respiratory distress
syndrome is an example of an acute inflammatory state which can progress to a
chronic and maladaptive inflammatory response. Levels of hyaluronan in the
bronchoalveolar lavage fluid from patients with ARDS were measured by ELISA,
and were found to be significantly elevated. The presence of hyaluronan was also
revealed in the alveolar interstitium of lung sections taken from patients with ARDS.
Elevated hyaluronan associated with ARDS may result in the escalation of
inflammatory responses. As the main immunocompetent cell in the lung is the
alveolar macrophage, the pro-inflammatory influence of hyaluronan on macrophage
responses may be instrumental in the pathogenesis and progression of disease.
Together the results presented in this thesis suggest a pivotal role for hyaluronan in
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1.1 The inflammatory environment
Inflammation is an important consequence of tissue injuries caused by various
stimuli such as physical trauma, bacterial and viral infections, xenobiotics and
autoimmune diseases. Acutely, inflammation is characterised by vasodilation,
increased vascular permeability, and cellular infiltration, a series of cellular and
molecular events, which act in concert to minimise tissue damage and eliminate the
provoking stimuli.
The inflammatory response is initiated through the vascular coagulation mechanism,
which is an overlapping and sequential series of events. A complex system of
circulating pro-enzymes, cofactors, and inhibitors leads to the activation of platelets
and the formation of a fibrin-platelet clot at the site of vascular injury. The
deposition of plasma fibrinogen, its conversion to insoluble fibrin and further cross-
linking with other fibrin molecules reinforces the platelet plug and forms a
provisional matrix, which provides a physical barrier to the spread of infection
(Brown et al., 1988). Thrombin release associated with coagulation leads to platelet
degranulation, which results in the release of chemotactic and growth promoting
cytokines at the inflammatory site (Raines and Ross 1982, Assoian and Sporn 1986,
Weyrich et al., 1996). Thus inflammation is delimited by the provisional matrix, yet
persists locally until the circumstances responsible for its initiation are resolved.
Control of inflammatory processes is ensured through local activation or release of
sequestered mediators at the inflammatory site, which initiate cellular recruitment
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and the process of repair. Vasoactive chemicals such as histamine (from mast cells
and basophils), prostaglandins (from polymorphonuclear cells, monocytes and
platelets) and leukotrienes (from neutrophils, mast cells and basophils) are produced
which rapidly increase vascular permeability and cause vasodilation. The increased
vascular permeability results in oedema, due to the leakage of plasma across the
endothelium, this inflammatory exudate ultimately drains to lymph nodes, where
initiation of antigen-specific immune responses may occur. Vasodilation provides
conditions that favour maximal infiltration of inflammatory cells (Busse 1979, Pecke
and Williams 1977, Bray et al., 1981).
Neutrophils are the first infiltrating cells in acute inflammation and arrive within
minutes (Hurley et ah, 1966). These highly phagocytic granulocytes are capable of
releasing a large number of histotoxic agents through degranulation (Haslett et ah,
1989), providing an effective defence against the spread of infection. During the
progression of inflammation the numbers ofmonocytes and lymphocytes gradually
increase (Issekutz et ah, 1981), these remove remaining debris and initiate repair.
Removal of granulocytes from the inflammatory site during the resolution of
inflammation is thought to involve apoptosis, followed by phagocytosis by
macrophages and other phagocytes (Savill et ah, 1989). Cells undergoing apoptosis
are characterised by a series ofmorphological and phenotypical changes (Wyllie et
ah, 1980, Savill et ah, 1989, Whyte et ah, 1993, Dransfield et ah, 1994) which serve
to functionally isolate the cells from potential pro-inflammatory stimuli and allows
them to be recognised and phagocytosed by macrophages. In contrast the fate of the
macrophage at inflamed sites is less well defined. Although monocytes and
macrophages are capable of undergoing apoptosis in vitro (Mangan et ah, 1991,
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Munn et al., 1995) macrophages in vivo, appear to leave the inflammatory site via the
lymphatics (Lan et al., 1993, Bellingan et al., 1996). In the lung, macrophages may
also be transported out by the mucociliary escalator (Weibel 1984).
Throughout the inflammatory process macrophages continue debridement through
active phagocytosis, and initiate the transition from inflammation to repair through
the secretion of growth factors that promote angiogenesis (Polverini et al., 1977)
which is essential for neovascularisation and connective tissue formation. The
recruitment of fibroblasts results in the laying down of various extracellular matrix
molecules (Ross et al., 1970), thereby promoting the formation of granulation tissue.
After considerable reorganisation, granulation tissue gradually disappears and is
replaced by the more organised and elastic extracellular matrix, which forms scar
tissue (Clarke 1990).
Reintroduction of, or failure to remove the inflammatory stimulus may lead to
conditions in which inflammation becomes chronic. Tissue macrophages are
principal regulators of inflammatory processes through the production of various
inflammatory mediators, including the cytokines interleukin-1, interleukin-8, and
tumour necrosis factor-a. The possibility that altered patterns of cytokine production




Monocytes, which make up 2-8% of peripheral blood leukocytes, are formed in the
bone marrow from progenitor cells (reviewed by Dorshkind 1990). Differentiation
from pluripotent progenitor cells is controlled by at least 11 different growth factors,
with IL-3 regulating the progression to myeloid restricted progenitors. These cells
then become responsive to M-CSF and GM-CSF which are responsible for their
maturation to monocyte/macrophage-restricted progeny (Rutherford et al., 1993).
Following release from the bone marrow, monocytes circulate in the bloodstream for
less than 72 hours prior to entering tissues (extravasation)( van Furth and Cohn 1968,
Volkman 1970, Whitelaw and Batho 1972) and can be considered to function as a
circulating pool for constitutive and induced recruitment. In the absence of
inflammatory stimuli, recruited monocytes may differentiate into resident
macrophages, with distinct phenotypes in different organs illustrating their potential
functional diversity.
There is some evidence that suggests that tissue macrophage populations may be
maintained by proliferation within tissues. Although monocyte precursor cells are
not produced to any great extent outside the bone marrow (van Furth and Cohn
1968), van Furth and Diesselhof-den Dulk (1984) showed that the spleen in mice
retains some haematopoietic activity and therefore a capacity for macrophage
production. Volkman et al., (1983) suggested that some proliferation may occur in
the lung, liver and peritoneal cavity, although the extent to which this occurs is not
certain.
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The phenotypic heterogeneity of macrophages has complicated the analysis of their
distribution within tissues. However, it is now well established that macrophages are
present throughout the connective tissues and around the basement membrane of
small blood vessels. They are particularly concentrated in the lung, liver, and lining
of spleen sinusoids and lymph node medullary sinuses, consistent with their proposed
role as scavenger cells in innate immunity. They are also capable of differentiating
into brain microglia, and osteoclasts in bone (Gordon 1995). Thus the differentiation
ofmacrophages is essential for their functional competence within different tissues.
A variety of environmental signals in situ modulate monocyte differentiation to
macrophages. Circulating monocytes extravasate in response to a chemotactic
gradient, requiring adherence to the vascular endothelium and migration involving
receptor-mediated transient cell-cell and cell-extracellular matrix adhesive
interactions. These adhesions are mediated through cell surface receptors and
represent the initial influence in monocyte to macrophage maturation.
Many adhesive surface molecules on monocytes have been described, which on the
basis of their biochemical properties can be grouped into three main families of
receptors; the immunoglobulin (Ig) supergene family, the selectins, and the integrins.
The Ig family members are composed of a number of extracellular Ig-like domains
arranged in tandem, which are either glycosylphosphatidylinositol (GPI)-linked e.g.,
CD 16, or have a transmembrane and a cytoplasmic domain (Williams and Barclay
1988). Examples include intercellular adhesion molecules 1, 2, and 3, VCAM-1, and
CD31 (reviewed by Springer 1990).
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The selectins comprise CD62E (E-selectin), CD62L (L-selectin), and CD62P (P-
selectin), and at a structural level contain an NH2-terminal lectin domain, an EGF-
like domain, consensus repeat sequences, a transmembrane domain, and a
cytoplasmic domain (Varki 1997). These molecules are involved in the loose
tethering of leukocytes to the vascular endothelium (Lawrence and Springer 1991).
The selectins are perfect for this role due to their molecular structure which extends
the lectin domain above the surrounding glycocalyx and allows them to sequestrate
passing leukocytes expressing the appropriate receptors (Lasky 1992). In addition to
a role in regulating the production of cytokines (Weyrich et al., 1995), adhesions
mediated by selectins allow the leukocyte to roll along the vessel wall "searching"
the endothelial surface for the presence of activating cytokines. Where such factors
are absent the transient nature of the selectin mediated adhesion allows the leukocyte
to continue rolling or to disengage and rejoin the circulation. In contrast,
inflammatory cytokine actions on the leukocyte convert functionally inactive integrin
molecules to an adhesive configuration (Detmers et al., 1990, Vaddi and Newton
1994, Weber et al., 1996). The integrins, so called because of their integral
membrane nature and role in the integrity of both the ECM and cytoskeleton
(Tamkun et al., 1986), are made up of an a-chain non-covalently linked to a P-chain
and provide strong adhesion to endothelium (Hynes 1987).
Beside these three main families, a variety of other molecular structures have been
shown to have a role in adhesion processes, including CD44 a molecule which was
first identified as a putative "homing" receptor for lymphocytes (Goldstein et al.,
1989, Stamenkovic et al., 1989). Several functions have been attributed to CD44,
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including binding to high endothelial venules (Jalkanen et al., 1988) binding to
collagen and fibronectin (Carter and Wayner 1988, Jalkanen and Jalkanen 1992) and
binding to hyaluronan (Aruffo et ah, 1990, Culty et al., 1990, Miyake et al., 1990).
Consistent with the suggestion that monocyte adhesion and the immediate micro-
environment provides signals which contribute to macrophage differentiation,
Henson and Riches (1994) proposed a number of maturation pathways in the mouse
resulting in functionally and phenotypically distinct macrophages. One such
pathway, induced by CD44 ligation with hyaluronan and the additional influence of
TNFa gave rise to an IGF-1 synthesising macrophage which might be considered
pro-fibrotic in function. Cytocidal macrophages, secreting reactive nitrogen
intermediates and complement factor b, may be derived from the combined
influences of interferons and TNFa on lipopolysaccharide-primed monocytes. A
more inflammatory macrophage, expressing lysosomal enzymes, is derived (in vitro)
through stimulation with (31,3-glucan (the principal constituent of yeast cell walls).
These data support the suggestion that there may be several routes for the
differentiation ofmonocytes to macrophages, resulting in functionally competent
cells adapted for specific microenvironments, in both inflammatory and steady state
conditions.
1.3 Macrophage Function
Macrophages play a central role in the maintenance of homeostasis in the immune
system, and are thought to be a key cell type the pathogenesis ofmany disease
processes.
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1.3.1 Macrophages as phagocytes
Macrophages are efficient phagocytes with a role in inflammatory processes,
identified as such at the turn of the century by Metchnikoff (1884). Phagocytosis can
be considered to involve 3 stages; recognition and binding, internalisation, and
digestion. Cell membranes carry a negative charge that keeps them apart and
prevents autophagocytosis, and the hydrophobic nature of the lipid bilayer prevents
hydrophilic bacterial cell wall components from entering the cell. To overcome these
difficulties, phagocytes have specific cell surface receptors that mediate the
attachment of opsonised particles. Macrophages have 2 receptors for IgA (FcaR)
(Maliszewski et al., 1990), and 3 types of receptors which bind to the Fc portion of
immunoglobulin G isotypes (reviewed by van de Winkel and Capel 1993). These are
FcyRI (CD64), FcyRII (CD32), and FcyRIII (CD16), FcyRI has a high affinity for
human monomeric IgG of all isotypes, whereas FcyRII and FcyRIII are low affinity
receptors, and bind aggregated IgG (Corvaia et al., 1995). Fc receptors are also
expressed on monocytes, and their ligation can induce monocyte activation (Mclntyre
et al., 1989). One feature ofmonocyte to macrophage maturation is the altered
expression of Fc receptors (Clarkson and Ory 1988). Opsonisation of particles by
complement components may result in the binding to surface receptors including
CD35 (complement receptor 1 or CR1) which binds C3b and C3dg, and the (32
integrin CD1 lb/CD18 and CD1 lc/CD18 which recognise iC3b (Wright et al., 1983,
Malhotra et al., 1986). Non-opsonised particles may be phagocytosed through the
co-operative action of different receptors, in particular those recognising
carbohydrate moieties. For example, the macrophage mannose receptor which
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mediates the binding and ingestion ofmicroorganisms with surface mannose residues
and soluble mannose-containing glycoproteins (Ezekowitz et al., 1990, Stein et al.,
1992). Alternative receptors capable of promoting opsonin independent phagocytosis
include P2 integrin (CD1 lb/CD18) (Greenberg 1995), scavenger receptors (Krieger
and Herz 1994) and p 1 integrins, even though these receptors generally do not
mediate efficient phagocytosis in the absence of ligand binding (Isberg and Tran van
Nhieu 1994). Receptor ligation leads to the particle becoming engulfed, and
destroyed by a variety of enzymes including lysosyme, and reactive oxygen or
nitrogen intermediates. Resident macrophages in different organs display phagocytic
functions to varying degrees, which may reflect the appropriateness for that particular
micro-environment. For example, alveolar macrophages are highly phagocytic,
possessing high levels of the mannose receptor, in contrast epidermal macrophages
(Langerhans cells) are poorly phagocytic but are highly efficient antigen presenting
cells.
1.3.2 Antigen presentation
Macrophages and dendritic cells are considered to be the classical antigen presenting
cells within lymphoid organs but macrophages are the primary antigen presenting
phagocytic cells. All nucleated cells express MHC class I molecules which are
involved in the presentation of endogenous antigen but MHC class II molecules are
involved in the presentation of exogenous and endogenous antigen. MHC Class II
molecules, which are heterodimers (composed of a 33-35kDa a chain and a 25-
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29kDa p chain) are also expressed on B-cells and activated T-cells (Brodsky and
Guagliardi, 1991).
T-cells are the effector cells in antigen responses and because the T-cell antigen
receptor does not recognise free antigen, macrophages must "present" antigen in a
form easily recognised. Antigen presentation involves the association of peptide
fragments derived from the antigenic proteins, with MHC class II molecules
(reviewed by Brodsky and Guagliardi 1991). Antigen that enters the tissues is
transported through lymph to the draining lymph node, either by antigen presenting
cells or free in the exudate. MHC Class II molecules assemble in the endoplasmic
reticulum with the invariant chain to form a stable trimer (reviewed by Sant and
Millar 1994). The invariant chain is a 3 l-43kDa glycoprotein which is thought to
inhibit the binding of peptides to MHC Class II in the endoplasmic reticulum
(Braciale and Braciale 1991). The invariant chain is proteolytically cleaved from the
MHC Class II molecule binding cleft in the endosome to allow degraded antigen to
bind and be transported to the cell surface where it can be presented to T-cells.
1.3.3 Secretion
In addition to their roles in phagocytosis and endocytosis, macrophages are capable
of secreting a variety of small and macromolecular products that mediate immune
responses, ranging in molecular mass from 30 (nitric oxide) to 440000 (fibronectin)
(Laskin and Pendino 1995). Other secreted products include cytotoxic agents such as
reactive oxygen and nitrogen intermediates, proteases, and lysosomal enzymes
released during the phagocytic response. Macrophages are also capable of producing
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a variety of growth factors and extracellular matrix proteins. Cytokine secretion, in
response to inflammatory agents, microbial invasion and tissue injury can contribute
to the resolution of inflammation and restoration of normal homeostasis. However
over- or underproduction of certain cytokines can contribute to pathogenesis of
diseases such as endotoxaemia and the acute respiratory distress syndrome (ARDS).
1.4 Macrophage Cytokines
Cytokines are usually low molecular weight glycoproteins that are produced by
various cell types and can act in an autocrine or paracrine manner. Cytokines often
induce synthesis of, and affect actions of other cytokines resulting in a complex
network. The macrophage plays a pivotal role in the cytokine network, producing
various pro-inflammatory cytokines (including TNFa, interleukin-1, interleukin-6,
and interferons), chemotactic cytokines (e.g., interleukin-8 and monocyte
chemotactic protein-1), and pro-fibrotic cytokines (e.g., transforming growth factor-
P) see table 1.
TNFa was first reported in 1975 as a protein in sera that caused tumour regression
when injected in mice (Carswell et al., 1975) and is responsible for the features of
septic shock once attributed to endotoxin (Beutler and Cerami 1986). It is expressed
as a 26kDa membrane-bound precursor containing a hydrophobic sequence that is
proteolytically cleaved by TACE (Black et al., 1997, Moss et al., 1997) to form the
mature 17kDa polypeptide. In solution, mature TNFa exists as a compact non-
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covalently linked trimer of 52kDa (Fiers 1993). Synthesis ofTNFa is stimulated by
numerous agents including bacterial cell wall derived lipopolysaccharide (LPS),
fungal products, and viral particles. Like many cytokines, expression ofTNFa is
controlled at the level of gene transcription and translation. Although unstimulated
monocytes express low levels ofTNFa mRNA, upon stimulation upregulation of
both translation and transcription of the gene product occurs within minutes (Beutler
et al., 1986). In murine macrophages TNFa signalling has been shown to involve
NFkB (Shakov et ah, 1990), however the involvement ofNFKB in the transcriptional
activation ofTNFa in human monocytes is more controversial. Goldfield et ah,
(1990) failed to show NFKB site involvement in the transcriptional activation of
human TNFa using murine monocytic cells, although TNFa has been suppressed by
inhibitors ofNFKB nuclear translocation in monocytic cell lines since then (Zeigler
Heitbrock et ah, 1993, Oeth and Mackman 1995). The data on TNFa signalling
pathways in human peripheral blood monocytes or human macrophages is lacking.
There are two distinct receptor sub-types for TNFa, designated p55 (55kDa) and p75
(75kDa) (Hohmann et ah, 1990, Brockhaus et ah, 1990). Within minutes of binding,
the receptor-ligand complex is internalised and before being degraded, the
intracellular signal is transmitted by mechanisms not yet elucidated. However, the
response of the cell correlates with the number of complexes internalised, thus
shedding of these receptors may provide a mechanism for down modulation of TNFa
activity. TNFa induces a number of proteins through the activation of transcription;
the induction ofCD62E on endothelium is achieved through NFKB (Read et al
1997), as is the activation of neutrophils (Macdonald et ah, 1997).
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Interleukin-1 has also been shown to be a pluripotent mediator in the pathogenesis of
inflammation. Although IL-1 does not appear to induce irreversible tissue damage
alone, it acts to potentiate many of the effects ofTNFa. IL-1 and TNFa both
increase the adhesiveness of endothelium for leukocytes via the upregulation of
CD62E and CD62P expression, integrin activation and induction of immunoglobulin
superfamily members ICAM-1 and VCAM-1 (reviewed by Beekhuiken and van
Furth 1993). Both cytokines have been shown to induce an aggressive matrix
degradative phenotype in fibroblasts (Pettipher 1986). The membrane bound form of
IL-1 is cleaved by a calcium dependent cysteine protease (interleukin-lB converting
enzyme or ICE) which has been identified and cDNA cloned (Thornberry 1992).
TNFa and IL-1 are released early in inflammation whereas other cytokines e.g.,
interleukin-6 and interleukin-8 are released later. Such evidence suggests that
inflammatory stimuli initiate a cytokine cascade sequentially involving TNFa
interleukin-1, interleukin-6, and interleukin-8. This suggestion is supported by
analysis of cytokine production in studies of disease progression in the inflammatory
disorder rheumatoid arthritis (Smolen et al., 1996).
15
Table 1. Principal macrophage cytokines and functions.
Cytokine MolecularWeight
(kDa)
Main Actions Target Cells
IL-la 17.5 pro-inflammatory T-cell, B-cell,
macrophage










IL-10 17-21 anti-inflammatory T-cell
IL-12 75(heterodimer of
40 and 35)
growth factor NK-cell, B-cell, T-
cell




IFNa 19-29 anti-viral most cells
TNFa 17 pro-inflammatory most cells






MIF 12 chemotactic macrophage




M-CSF 45-90 haematopoietic macrophage
G-CSF 19.6 haematopoietic neutrophil






TGF-(3 11.5-12.5 growth factor fibroblast
bFGF 16 growth factor fibroblast
IGF-1 6 growth factor fibroblast
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Interleukin-6 is a typical example of a multifunctional cytokine. First identified as a
distinct hepatocyte stimulating factor involved in the induction of the acute phase
response, it also induces differentiation of T-cells, B-cells, and macrophages, and is a
potent growth factor for human myeloma cells (Akira 1992). Binding of IL-6
receptors induces the association of an accessory signal transducing molecule
(gpl30) which may also associate with several other cytokines including LIF
(leukaemia inhibitory factor) and IL-11 (Kishimoto et ah, 1995). This ligand-specific
receptor with associated common signal transducer for multiple cytokines is found in
most haematopoietic cytokine receptor systems and may explain the functional
pleiotropy and redundancy of cytokines.
A principal chemoattractant for neutrophils (Peveri et ah, 1988), IL-8 is also
associated with various acute and chronic inflammatory states. In addition to
bacterial-derived products such as LPS, both TNFa and IL-1 are capable of
stimulating macrophage production of IL-8 (Strieter et ah, 1990). Other actions of
IL-8 include the induction of neutrophil polarisation and degranulation (Peveri et ah,
1988) and altered adhesion receptor expression (down-regulating L-selectin and
increasing CD1 lb/CD 18 expression) (Detmers et ah, 1991, Luscinskas et ah, 1992).
IL-8 binds to G-protein coupled receptors which have 7 transmembrane domains
(Holmes et ah, 1991).
Monocyte chemotactic factors include the TGF(3 family of proteins, which also
function in tissue remodelling during angiogenesis. There are 3 mammalian TGFPs
which are often coexpressed in similar cell types and have similar actions in vitro
(Derynck et ah, 1985). TGFp is released from platelets and macrophages combined
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with a carrier protein (latent TGF(3) which is cleaved by low pH or certain proteases
to become active TGF(3. In vivo TGF(3 is immunosuppressive (Tsunawaki et al.,
1988,Wahl et al., 1988) yet stimulates monocyte and fibroblast migration (Wahl et
al., 1987, Wiseman 1988, Postlethwaite 1987) and induces production of
extracellular matrix components by fibroblasts (Ignotz and Massague 1986, Fine and
Goldstein 1987) and type II alveolar epithelial cells (Maniscalco et al., 1994, 1994a).
1.5 Extracellular Matrix
The extracellular matrix (ECM) is often considered as the scaffolding that supports
the cellular elements of various tissues. It provides stability and support, separates
epithelium or endothelium from interstitium, and thereby serves as a physical barrier
by which tissues are compartmentalised. In addition, various cells e.g., fibroblasts,
chondrocytes, endothelial cells and macrophages surround themselves in tissue
culture by a pericellular ECM layer which excludes particles such as red blood cells
and bacteria (Clarris and Fraser 1968) and may afford protection against compression
in vivo.
Major ECM components include collagens, glycoproteins, and proteoglycans
(Reichardt 1992). The structure and function of any connective tissue depends on the
relative proportions of these constitutive molecules. Collagens are the main fibrous
structures of connective tissues, characterised by 3 polypeptide chains, which form a
triple helix basic unit (Prockop and Kivirriko 1995). For 80-90% of collagens in the
body the triple helix represents the major part of the molecule (Ayad et al., 1994),
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these are types I, II and III which are the classical fibril forming collagens. Types V
and XI are also classified as fibrillar based on their homology to types I-III. The
other collagens deviate considerably from this group both in structure and function
within the ECM.
1.5.1 Glycoproteins
Matrix glycoproteins represent a heterogeneous group of structurally diverse
molecules including fibronectin, tenascin, vitronectin and laminin, which comprise a
core protein with carbohydrate covalently attached.
Fibronectin is a ubiquitous glycoprotein present in most extracellular matrices and in
plasma. Like other glycoproteins, fibronectin is a mosaic protein composed of
modular units (reviewed by Potts and Campbell 1994), and is secreted as a dimer
which associates into disulphide-bonded oligomers and fibrils to produce the
insoluble form in ECM, whereas the soluble form found in plasma remains mainly
dimeric, polymerising when exudated from plasma. One of the main functions of
fibronectin is the ability to promote cell adhesion, especially during wound healing
and fibrosis (Grinell 1984). The site that promotes cell adhesion is located in the
middle portion of the molecule, and involves an RGD sequence (Arg-Gly-Asp)
which is a common motif recognised by integrins (reviewed by Gille and Swerlick
1996). Increased levels of fibronectin have been shown in lung injury and repair
(Rennard et al., 1981, Broekelman et al., 1991), and soluble fibronectin has been
shown to modulate cytokine production by monocytes (Beezhold and Personius
1992, Peat et al.,1995, Graves and Roman 1996).
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Vitronectin, like fibronectin, also mediates various functions in coagulation,
promotes adhesion to a variety of cell types (Felding-Haberman and Cheresh 1993)
and is found in wound fluid (Grinnel et al., 1992). Elevated levels of vitronectin
have been found in the synovial fluid of patients with rheumatoid arthritis
(Rosenblum and Carsons 1996), and in the BAL fluid of patients with sarcoidosis
(Eklund et al., 1992).
1.5.2 Proteoglycans
Proteoglycans are a diverse group ofmolecules comprised of a core protein attached
to one or more covalently linked glycosaminoglycan (GAG) side-chains. Their
diversity is determined by variation in the core protein, and in the type and size of the
GAG chains. These GAG chains are composed of repeating disaccharide units, and
include chondroitin sulphate, dermatan sulphate, keratan sulphate, and heparan
sulphate. Heparan sulphate is the most abundant proteoglycan in basement
membranes (Sivaram et al., 1995), and is thought to be important in inflammation,
particularly through the sequestration of cytokines (Vlodavski et al., 1995, Jackson
1997).
1.5.3 Hyaluronan
Structurally related to heparan sulphate, hyaluronan is a high molecular weight linear
non-sulphated GAG containing alternating N-acetyl-D-glucosamine and D-
glucaronic acid residues linked by (3(1-4) and P(l-3) bonds. In solution it exists in a
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random coiled configuration, which is highly hydrated and thus has an important role
in tissue hydration.
Hyaluronan is a widely distributed ECM component, it acts in embryonic
development (Fisher and Salrush 1977), tumour growth (Sy et ah, 1996, Naor 1997),
wound healing (Bentley 1967,1968), as a provisional matrix for the support of cell
migration and growth (Weigel et al., 1986, Peck and Isacke 1996), and in
combination with other proteoglycans is a major component of pericellular matrices
(Hedman et al., 1982, Lee et al., 1993).
During inflammation hyaluronan undergoes dynamic regulation, elevated levels of
hyaluronan have been found in the serum of patients with rheumatoid arthritis
(Emlen et al., 1996), and sepsis (Laurent et al., 1996a). Whereas reduced levels and
altered molecular weight forms of hyaluronan have been found in the synovial fluid
of patients with rheumatoid arthritis (Dahl et al., 1985). During inflammation,
hyaluronan and fibronectin accumulate in the fibrin provisional matrix and have been
recovered from the air-lung interface after the onset of acute lung injury (Bray et al.,
1991).
1.6 Receptors for Hyaluronan
Receptors for hyaluronan include RHAMM (receptor for hyaluronan mediated
motility) and CD44. RHAMM is expressed at low levels on many quiescent cells,
including macrophages (Turley 1992), and as the name suggests, is involved in cell
motility (Hall et al., 1994).
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The principal receptor for hyaluronan is thought to be CD44, the most common form
is the smallest (80-95kDa), and is a single chain molecule composed of a distal
extracellular domain, which contains the ligand binding sites, a transmembrane-
spanning domain, and a cytoplasmic tail. As both hyaluronan and CD44 are
ubiquitously expressed it is probable that extensive variations in the structure of
CD44 govern the adhesive interactions between them.
CD44 is subject to post-translational modifications, such as glycosylation (Goldstein
et al 1989), and phosphorylation (Neame and Isacke 1992). In addition, 10
alternative splice regions within the genomic organisation (exons vl-vlO) provide
CD44 with great molecular diversity. Within the variable region, there are a further 4
potential N-glycosylation sites, and several potential O-glycosylation sites, in
addition to a potential insertion motif (serine-glycine) for glycosaminoglycans
(Screaton et al., 1993).
The cytoplasmic tail is highly conserved (Goldstein et al., 1989, Stamenkovic et al.,
1989) and contains 6 potential phosphorylation sites, of which some are
constitutively phosphorylated (Carter and Wayner 1988, Camp et al 1991). In
addition, there are consensus phosphorylation sites for protein kinase C and protein
kinase A (Camp et al 1991). Further diversity is provided by the 4 serine-glycine
motifs in the extracellular domain, which can be modified by heparan sulphate
(Tanaka et al., 1993) and chondroitin sulphate (Jalkanen et al., 1988, Stamenkovik et
al., 1989). These modifications could possibly result in altered ligand specificity
(Jalkanen and Jalkanen 1992). In fact, CD44 can act as a receptor for several other
ECM components including collagen (Carter and Wayner 1988), fibronectin, and
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laminin (Jalkanen and Jalkanen 1992). In addition some non-ECM ligands have been
reported including osteopontin (Weber et al., 1996).
1.7 ECM, and cell interactions
In addition to its structural role the ECM provides a context in which cellular
reactions can occur. Matrix proteins also confer signals regulating cell growth and
activation. Leukocyte adhesion to ECM, as previously mentioned, is one of the first
influences on monocytes as they extravasate. It is important as a cell-activating
event, and adhesion to different ECM proteins has been reported to affect;
• Spreading (Edwards et al., 1993).
• Cytoskeletal changes (Mueller et al., 1989)
• Focal adhesion assembly (reviewed by Otey and Burridge 1990).
• Stimulation of proliferation and migration (Adams and Shaw 1994, Vlodavski et
al., 1995).
• Induction of cytokines and chemokines (Eierman et al., 1989, Neese et al., 1994,
Formica et al., 1994, Peat et al., 1995).
• Alterations in phagocytic behaviour (Newman and Tucci 1990, Suzuki and
Yamaguchi 1993).
• Alterations in reactive oxygen and nitrogen intermediates (Formica et al., 1994,
Gudewicz et al., 1994).
1.8 ECM, Cytokines and Cell Responses
Several cytokines including IL-3, GM-CSF and several forms of fibroblast growth
factor (FGF) are functionally active when bound to proteoglycans in ECM (Nathan
1991). IL-8 becomes a more potent chemoattractant when bound to heparan sulphate
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(Webb et al., 1993). The structure of proteoglycans is ideal for the presentation of
cytokines because of the long highly charged and hydrophilic GAG chains. Like the
selectins these chains can reach the periphery of the glycocalyx where they may
capture cytokines released from the endothelium or underlying tissue and present
them to loosely tethered leukocytes (Tanaka et al., 1993). The structural variation of
proteoglycans on endothelium may add specificity to these interactions by regulating
which cytokines are retained. So site-specific or activation-specific endothelial
proteoglycans may bind and present different proadhesive cytokines to particular
subsets of leukocytes (Adams and Shaw 1994).
In addition, many cell responses to cytokines are altered when the cell is bound to
ECM proteins through initiation of adhesion-dependent signal transduction e.g.,
TNFa acts as a secretagogue for neutrophils only when adhered to ECM via P2
integrins (Nathan and Sanchez 1990, Shappel et al., 1990, Richter et al., 1990).
1.9 ECM Turnover
Events in wound healing can be divided into 3 stages; inflammation, early and late
granulation tissue formation (Gailit and Clarke 1994). Each stage requires the
carefully controlled synthesis and removal of the various structural proteins,
glycoproteins and proteoglycans of the ECM. The degradation ofECM is achieved
through the interactions between cells, cytokines, proteases, and protease inhibitors.
During inflammation neutrophils and macrophages release proteases and reactive
oxygen intermediates (Laskin and Pendino 1995). These products may be involved
in the degradation of ECM components exposed after endothelial injury (Baker et al.,
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1989). Macrophage production of the various proteases capable of degrading ECM
components, including matrix metalloproteases, appears to be regulated by contact
with the ECM itself (Shapiro et al., 1993) and cytokines (Wahl and Corcoran 1993).
Although leukocytes need to be able to degrade ECM in order to respond to
inflammatory stimuli and migrate successfully through ECM barriers, the
uncontrolled production of these degradative products can result in excessive ECM
disruption. As ECM can bind and sequestrate growth factors necessary for repair of
injured tissue these may be released during this degradation, either hindering the
resolution of inflammation or leading to disease pathogenesis. Clearly there is a
complex interplay ofmediators in inflammatory processes, involving inflammatory
cells, cytokines and ECM components. In the lung, the abnormal regulation of these
processes may result in parenchymal lung destruction.
1.10 Inflammation in the lung
Historically, the lung was perceived as an organ primarily involved in gas exchange,
however it also plays an important role in mediating host defence. Upon exposure to
inhaled immunogens one response ofpulmonary epithelial cells in addition to their
role in mucociliary clearance through the secretion ofmucous and efficient ciliary
movement in the upper airways, is synthesis and release of a number of cytokines and
other inflammatory mediators. Alveolar macrophages and leukocytes within the
extensive alveolar capillary network also provide an important defence against blood
borne immunogens. Following generation of an inflammatory response and the
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clearance of the initiating agent, inflammation is resolved and normal repair and
tissue remodelling re-establishes normal lung function without the development of a
pulmonary fibrotic response. In chronic inflammation within the lung, the process of
healing through scar formation or fibrosis may reduce the capacity for gas exchange
and have serious consequences for normal lung function that might ultimately affect
host survival.
1.11 Adult Respiratory Distress Syndrome
The most severe form of acute lung injury is the adult respiratory distress syndrome
(ARDS), which develops most often 24-72 hours after the provoking insult
(Donnelly and Haslett 1992). Originally described in 1967 (Ashbaugh), ARDS is an
example of an acute inflammatory response that frequently progresses to a fibrotic
condition. Initially, it is characterised by a leakage of proteinaceous fluid into the
interstitium and airspaces. Type I epithelial cells which facilitate the exchange of gas
across their thin cytoplasm in normal lung function, provide a barrier to the
movement of fluid into the airspaces (Bachofen et al., 1982). In ARDS, extensive
injury of these type I epithelial cells results in the disruption of the epithelial layer
and allows the leakage of fluid and proteins into the alveolar spaces, this is
accompanied by an excessive neutrophil influx. During disease progression, type II
epithelial cells, which are more resistant to injury, proliferate and replace type I cells
(Riede et al., 1979). In response to common precipitating insults, including multiple
trauma, pancreatitis, and endotoxaemia, a microenvironment that favours cell injury
is created in part through the release of pro-inflammatory mediators such as TNFa
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(Armstrong and Millar 1997) and IL-1 (Pugin et al, 1996), and chemotactic agents
such as IL-8. These cytokines prime and activate neutrophils and other inflammatory
cells to release histotoxic agents including proteases and reactive oxygen species,
which are capable of damaging extracellular matrix components exposed after the
destruction of epithelial or endothelial cells (figure 1.1). Analysis of bronchoalveolar
lavage fluid obtained from patients with ARDS has revealed elevated levels ofTNFa
(Millar et al., 1989) and IL-1 (3 (Suter et ah, 1992), both of which can stimulate
production of IL-8 by endothelial cells (Huber et al., 1991), and macrophages
(Strieter et al., 1990). In fact, in addition to elevated IL-8 levels in bronchoalveolar
lavage fluid from patients with ARDS (Miller et al., 1992), elevated levels of IL-8
have been found in the lavage fluid of patients at risk ofARDS who subsequently
progressed to ARDS (Donnelly et al., 1993).
Some patients with ARDS recover rapidly as alveolar structure and function are
regained, however ARDS has an associated mortality rate of 50%. In those patients
who die from ARDS, a fibroproliferative process occurs, which is poorly understood,
but is characterised by fibrin deposition in the alveolus. In addition, fibroblasts and
myofibroblasts proliferate within the alveolar wall, and migrate through the denuded
basement membrane depositing scar tissue matrix proteins (Raghu et al., 1985) which
leads to fibrosis (Bitterman et al., 1992). The subsequent proliferation of
mesenchymal cells within the alveoli and the formation of new capillaries, results in
the obliteration of normal lung architecture (Tomashefski et al., 1983).
It is probable that the neutrophil influx during ARDS and consequent lung damage
results from mediators produced by cells already resident in the lung. Under normal
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conditions and during chronic inflammation, the most abundant immune cell in the
lung is the macrophage. However, little is known about the mechanisms of
macrophage activation in this type of inflammatory environment.
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1.12 Aims
The work presented in this thesis aimed to characterise the monocyte/macrophage
activation seen in inflammatory environments such as that seen in ARDS.
Initially I undertook a comparative phenotypical analysis ofmonocytes and
monocyte-derived macrophages, with the aim of investigating alveolar macrophages
obtained from patients with ARDS and those at risk of developing ARDS. These
studies are described in chapter 3.
Secondly, I developed an in vitro model for assessing the effects of altered
composition on inflammatory macrophage phenotype using human peripheral blood
monocytes and monocyte-derived macrophages. Hyaluronan, a key ECM component
was found to have pro-inflammatory actions on monocytes and was investigated
further (described in chapter 4).
Thirdly, the clinical relevance of pro-inflammatory actions of hyaluronan was
investigated, by quantifying hyaluronan in clinical material (bronchoalveolar lavage
fluids and lung biopsy specimens), obtained both from patients with ARDS, and
patients at risk of developing ARDS (described in chapter 5). Finally, the pro¬
inflammatory effects of hyaluronan on monocytes and macrophages were further
characterised through receptor blocking studies and studies on cell survival.
The overall intent was that these combined approaches would provide some insight
to the role of the extracellular environment in determining inflammatory





Tissue culture media, including Dulbecco's Modified Eagles Medium (DMEM),
Iscove's Modified Dulbecco's Eagles Medium, Hanks balanced salts solution, L-
glutamine, penicillin and streptomycin, were obtained from Life Technologies
(Paisley, UK). Sterile disposable tissue culture ware was from Falcon Plastics,
Becton Dickinson, (Oxford, UK). Dextran T500 and Percoll were obtained from
Pharmacia Biotechnology (St. Albans, Herts.), all other chemicals, unless otherwise
stated, were obtained from Sigma Diagnostics (Poole, UK).
2.2 Materials and Methods
2.2.1 Alveolar macrophage isolation and culture
Bronchoalveolar lavage (BAL) was performed on normal volunteers (smokers and
non-smokers), patients at risk of ARDS, and patients with ARDS. BAL was
performed by Drs. S.C. Donnelly, P. Reid, and D. Morrison. Briefly, 3 x 60ml 0.9%
NaCl was instilled into the right middle lobe and gently aspirated immediately. BAL
fluid was then strained through sterile gauze to remove mucous, and then spun at 400
x g at 4°C for 10 minutes to recover cells. Cell numbers and viability were
determined by trypan blue exclusion using a haemocytometer (section 2.2.17). Cells
were washed in HBSS, and either re-suspended in PBS with 0.2% BSA, and 0.1%
sodium azide for flow cytometry (section 2.2.17), or re-suspended in Iscove's
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modified Dulbecco's Eagles medium (Iscove's DMEM) and allowed to adhere for
lhr (37°C, 5%C02) to tissue culture plastic. Adherent cells were washed after lhr
with gentle pipetting with HBSS to remove non-adherent cells and cultured in
Iscove's DMEM with 10% myoclone + foetal calf serum.
2.2.2 Flow Cytometry
Cells for flow cytometric analysis were resuspended at 2 x 106/ml in cold PBS with
0.2%BSA, and 0.1% sodium azide, and 50pl cell suspension was used per test. To
block non-specific binding of antibody through Fc receptors, cells were pre-incubated
with 20% normal rabbit serum for 20 minutes. All antibodies were used at saturating
concentrations, as determined by titrations.
2.2.3 Indirect technique
Antibodies (50pl per test, listed in table 2.2) were added to the cell pellet in 96 well
flexible assay plates (Falcon), and incubated on ice for 30 minutes. Cells were then
washed twice in PBS/BSA/Azide to remove unbound antibody, centrifuged at 225 x
g and resuspended in fluorescein isothiocyanate-conjugated F(ab')2 goat anti-mouse
immunoglobulin (Dako corporation, High Wycombe, Bucks.) diluted 1:40 in
PBS/BSA/Azide. Alternative second layer conjugates were used on autofluorescent
macrophages; Tri-colour (Bradsure Biologicals, now TCS Biologicals,
Botolphclaydon, Bucks.), and Quantum Red (Sigma). Following a 30 minute
incubation on ice with the second layer, cells were washed twice (as before), and
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either resuspended in PBS/BSA/Azide and analysed immediately, or fixed in 3%
formaldehyde in PBS and kept at 4°C, protected from light until analysed.
2.2.4 Direct technique
Phycoerythrin-conjugated anti-CD 14 monoclonal antibody was added to the cell
pellet and incubated for 30 minutes on ice. Following two washes (as before) cells
were analysed immediately. Flow cytometric analysis was performed using an
EPICS Profile II flow cytometer (Coulter Electronics, Luton, Beds.).
2.2.5 Autofluorescence Quenching
Crystal violet (Sigma) was dissolved (2mg/ml) in sterile PBS and filtered. Cells
were treated with crystal violet prior to indirect immunofluorescent staining (section
2.2.3) then fixed in 3% formaldehyde/PBS. Alternatively, cells were subject to
indirect staining, fixed in 4% paraformaldehyde, permeabilised with n-octyl-(3-D-
glucopyranoside (OG, Sigma), then treated with crystal violet according to Hallden et
al., (1991). Flow cytometric analysis was performed using an EPICS Profile II flow
cytometer, as before.
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Table 2.1 Antibodies for Flow Cytometry
Antibody Flow dilution Supplier
MOPC Neat, supernatant MOPC31C, hybridoma,
ECCC
CD3 Neat UCHT1, hybridoma,
ECCC
CDlla 1:8 Serotech, Oxford
CDllb 1:4 Serotec, Oxford
CDllc 1:4 SAPU, Carluke,
Lanarkshire
CD14 1:4, supernatant UCHM1, hybridoma,
P.Beverley.
CD14-PE 1: 25, Tuk-4, Dako
CD15 1:8 Serotec, Oxford
CD 16 Neat, supernatant 3G8 hybridoma,
J.Unkeless,
CD43 1:4 Serotec, Oxford
CD44 (5A4) Neat, supernatant 5A4 hybridoma
G.Dougherty
CD44 (7F4) Neat, supernatant 7F4 hybridoma,
G.Dougherty
CD44 (v3) 1:500 Becton Dickinson
CD44 (v7-8) 1:100 Bender
CD44 (vlO) 1:1000, Ascites G.Dougherty, Los
Angeles
CD51 1:4 Becton Dickinson
CD62L (LEU 8) 1:8 Becton Dickinson
CD66b (HLA-DR) Neat, supernatant SAPU, Carluke,
Lanarkshire
CD67 1:200 Becton Dickinson
CD69 (LEU23) 1:4 Becton Dickinson
CD71 1:8 Becton Dickinson
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2.2.6 Monocyte isolation
Mononuclear cells were isolated from peripheral blood from normal donors. Blood
(40ml) was obtained by venipuncture and anti-coagulated with 0.38% sodium citrate
in sterile 50ml tubes (Falcon). Tubes were then centrifuged at 300 x g for 20 minutes
(MSE Mistral 3000 Sanyo Gallenkamp, Loughborough UK) at room temperature
(22°C) to yield a cell-rich pellet and a platelet-rich upper layer.
Autologous serum was prepared by adding 330pl calcium chloride (0.32%) to 15ml
platelet-rich plasma (PRP) in glass tubes, and incubating at 37°C. Platelet poor
plasma (PPP) was prepared by centrifuging the remaining PRP at 2500 x g for 20
minutes.
Erythrocyte sedimentation was performed by addition of 2.5ml ofwarm (37°C) 6%
Dextran T500 per 10ml of leukocyte-rich pellet. Cell pellets were made up to 50ml
with warm saline and allowed to sediment at room temperature for 30 minutes.
Isotonic Percoll was prepared by adding 3ml of lOx PBS without calcium or
magnesium to 27ml Percoll (Pharmacia), and discontinuous density gradients were
prepared by overlaying an 81% isotonic Percoll layer with a 70% layer. The
leukocyte rich upper layer was washed in saline and re-suspended in 55% isotonic
Percoll which was then layered onto the gradients. Gradients were centrifuged at 720
x g for 20 min (Dooley et ah, 1981).
Mononuclear leukocytes were aspirated from the 55%/70% interface and washed
twice in HBSS without calcium or magnesium.
35
Cell number and viability were assessed by trypan blue exclusion on a
haemocytometer (section 2.2.17). Purity was assessed by flow cytometry, according
to forward scatter and side scatter characteristics (section 2.2.4)(figure 2.1a).
2.2.6a) Adherence isolation of monocytes
Monocytes were isolated by adherence to autologous plasma-coated tissue culture
plates, adapted from Ackerman (1978). 10cm petri dishes were coated using 10%
autologous PPP in PBS without calcium or magnesium and incubated for 30 minutes
at 37°C. The plates were washed in PBS to remove any remaining platelets before
adhering the cells. Mononuclear cells were allowed to adhere for 1 hour (37°C,
5%C02) in Iscove's DMEM with 10% autologous serum, after which time non¬
adherent cells were removed by washing four times in warm HBSS. Adherent cells
were detached using 5mM EDTA in PBS with 2% autologous serum for 5 min at
37°C. Cells were then washed in Iscove's DMEM with 10% serum and additives
(penicillin, 0.5u/ml, streptomycin, 0.5U/ml) (monofeed), and checked for purity and




A. Mononuclear leukocytes from the 55%/70% interface of discontinuous Percoll
density gradients were checked for purity by flow cytometry on the basis of
forward and side scatter characteristics; monocytes are shown in gate B, whereas
gate A shows lymphocytes.
B. Monocytes isolated by adherence to plasma-coated plates were also assessed for
purity by flow cytometry, according to forward scatter and side scatter
characteristics.
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2.2.6b) Counter Current Centrifugal Elutriation
Cell elutriation was performed using a J-21M/E Beckman centrifuge (Beckman
Instruments (UK.) Ltd, High Wycombe, UK.) with a JE-6 elutriator rotor with flow
rate regulated by a peristaltic pump (figure 2.2). The leukocyte-rich layer, prepared
by Dextran sedimentation was loaded into the elutriation chamber at a rotor speed of
2200rpm with a fixed flow rate of 6ml/min. The pump speed was gradually
increased, allowing the cell interface in the elutriation chamber to settle between each
increase, and cells were elutriated according to their size and density. Cell
populations were monitored through regular sampling and flow cytometry (section
2.2.4). Cells were collected in 50ml fractions, washed in HBSS and checked for
viability (section 2.2.17).
Initial elutriation runs performed at room temperature in the presence of autologous
plasma resulted in low cell yields after 24 hours in culture, or total cell death.
Although the elutriator tubing was sterilised with ethanol prior to each run,
accumulation of plasma proteins from different donors could result in cell activation
and possibly cell necrosis. Autologous plasma was substituted with foetal calf serum
(FCS) and the buffer and rotor cooled to 4°C prior to use.
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These alterations resulted in a reduction of total elutriation times and increased
viable cell yields.
2.2.6c) Comparison of Isolation Techniques
To determine if one leukocyte isolation method resulted in better yields and survival
rates than the other, a comparison was made. Flow cytometric analysis (figure 2.3)
showed that when compared to Percoll isolated neutrophils, elutriated neutrophils
had reduced expression of CD62L, suggesting that these cells were more activated.
In a separate experiment (data not shown) rates of neutrophil apoptosis were found to
be increased for the elutriated neutrophils. These data together would suggest that
elutriation was resulting in neutrophil activation and decreased cell survival rates,
when compared with Percoll isolated cells. Monocyte survival over 6 days in Teflon
was comparable for the two different isolation procedures (table 2.1)
Table 2.1 Comparison of Elutriated and Percoll Separated cell survival
Donor Method Day 1 Yield Day 6 Yield % Survival
(xlO6) (xlO6)
1 Percoll 20 0.01 0.05
Elutriated 20 0.32 1.6
2 Percoll 6.0 0.6 10.0
Elutriated 7.0 0.33 4.7
3 Percoll 20 3.3 16.5




Neutrophils isolated by elutriation were compared with neutrophils isolated by
Percoll density gradients for expression of CD62L, and CD1 lb, through flow
cytometric analysis, to assess the cell activation between techniques. A; negative
control, B; Percoll isolated neutrophil CD62L expression, C; elutriated neutrophil
CD62L expression, D; Percoll isolated neutrophil CD1 lb expression, E; elutriated
neutrophil CD1 lb expression.
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However, elutriated monocytes cultured adherent to tissue culture plastic (data not
shown) did not adhere firmly and by day 6 were easily washed off. Considering these
data, and due to the nature of elutriation, which has multiple opportunities for system
errors and contamination, Percoll separation was chosen as the preferable method for
reliable yields ofmonocytes.
2.2.7 Monocyte culture
Monocytes were cultured for 6 days in monofeed at a density of 10^ cells/ml, either
adherent to tissue culture treated plastic (Falcon) or in suspension in hydrophobic
Teflon foils (section 2.2.8.a). Medium was changed at day 3 for adherent cultures.
2.2.8 Preparation for Cell Culture
2.2.8a) Teflon Foils
Hydrophobic Teflon foils were prepared by taking 5cm squares of Teflon (Chemfab,
Handforth, Cheshire, UK) and folding 1cm in of each edge (figure 2.4). Corners
were then sealed using a modified HM3000 Impulse heat sealer (Hume Martin Ltd,
London, UK), and the Teflon foils were autoclaved prior to use.
2.2.8b) ECM Plates
For ECM plates, tissue culture treated plastic was coated overnight at 4°C with




Hydrophobic Teflon trays were prepared with 5cm squares of Teflon, and 1cm was
folded in at each edge (A). Corners were then sealed using a modified HM3000
Impulse heat sealer (B). Edges were trimmed and the teflon trays were autoclaved
prior to use.
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2.2.9 Morphological Assessment of Apoptosis
Apoptosis was assessed using Acridine Orange (Sigma) which intercalates with DNA
to emit a green fluorescence. During apoptosis chromatin condenses and apoptotic
monocytes are easily recognised by the bright green stained nucleus. Acridine
Orange (0.5pi) was added directly to the wells to give a final concentration of
1 pg/ml, this was sufficient to stain the cells without high background fluorescence.
2.2.10 Immunohistochemical Staining Lung Tissue Sections
Paraffin embedded lung biopsy samples, kindly provided by Edinburgh University
Pathology department, were cut into sections and mounted on Poly-L-Lysine coated
slides. These were de-waxed in xylene, sequentially re-hydrated in 100% ethanol,
70% ethanol, 55% ethanol, then washed in running water. Slides were blocked for
endogenous peroxide with 1% H202 (15 minutes) then blocked (20 minutes) for non¬
specific binding in Tris buffered saline (pH 7.6) 1% bovine serum albumin (BSA).
Slides were then incubated (overnight, 4°C) with biotinylated hyaluronan binding
region (HaBR, kindly provided by Mike Bayliss, Kennedy Institute, London) diluted
in TBS 1% BSA. Slides were washed in TBS then incubated (1 hour) with
streptavidin-biotin-HRP (Dako corporation, High Wycombe, Bucks.) diluted 1:500 in
TBS containing 1% BSA. After further washing, staining was visualised using 3,3'
Diaminobenzidine (DAB, 500pg/ml in Tris/HCl pH 7.6 with 1% H202), this
substrate reaction was stopped by rinsing slides with water. Slides were then
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counter-stained with Haematoxylin blue prior to re-hydrating sequentially in 55%,
70%, and 100% ethanol, finally slides were rinsed in xylene, and mounted.
To control for non-specific staining, HaBR was adsorbed (overnight, at 4°C) onto
high binding flat bottom 96 well plates (Corning Costar, high Wycomb, Bucks.) pre-
coated with hyaluronan (lmg/ml). Slides used for negative controls were treated in
the same manner as before using this HaBR that had been pre-adsorbed onto
hyaluronan in solid phase.
2.2.11 Cell adhesion assay
A quantitive method for assessing cell adhesion was modified from Oliver et al.
(1989). High binding 96 well plates (Maxisorp, Nunc Life Technologies, Paisley)
were pre-coated with hyaluronan (lmg/ml), fibronectin (10pg/ml), keyhole limpet
haemocyanin (10|Lig/ml)(Sigma), or sterile BSA (0.2%). Monocytes (at 2 x 106/ml,
or 0.5 x 106/ml) were allowed to adhere for 30 minutes at 37°C in HBSS, or HBSS
without calcium or magnesium in the presence of 5mM EDTA. Plates were then
washed twice in HBSS and fixed with 4% formalin in PBS. Remaining cells were
then stained with 1% methylene blue for 30 minutes, washed with distilled water, and
lysed in 0.1N HC1. Optical densities were determined at 630nm (Dynatech MR5000
plate reader Billinghurst, Kent). Alternatively, assays were assessed by microscopy,
the number of adherent cells in 4 randomly selected fields were counted in each well.
The edges of the wells were avoided, where cells remained adherent to different
substrates throughout the washing procedures.
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2.2.12 Cell Bound ELISA
Mononuclear cells (5 x 106/ml) were plated onto a 96 well tissue culture plate
(150p,l/well) and allowed to adhere (37°C, 5% C02) for 1 hour. After washing in
- HBSS to remove non-adherent cells, monocytes were cultured overnight in
monofeed. Adherent cells were then washed twice with PBS 0.1%BSA and
incubated with antibodies for 1 hour at room temperature. After washing three times
with PBS/BSA/Azide, cells were either fixed with 4% paraformaldehyde or left
unfixed then incubated with P-galactosidase-conjugated goat anti-mouse IgG
(1:1000, Sigma) for 1 hour at either 37°C or room temperature. The enzyme P-
galactosidase was chosen as an alternative to peroxidase-conjugated enzyme systems,
to avoid any interference from endogenous peroxidase activity. After washing again,
o-nitrophenyl p-D-galactopyranoside (ONPG) substrate (4mg/ml) in 0.1M sodium
phosphate with 0.1M MgCl2/4.5M P-mercapto-ethanol was added and colour
allowed to develop. Substrate reaction was stopped using 1M NaC03, and after
transferring the supernatant to a fresh 96 well ELISA plate, absorbance was read at
405nm using a plate reader (MR5000 Dynatech, Billinghurst, Kent.).
2.2.13 ELISA
2.2.13a) Antibodies
Paired TNFa monoclonal antibodies were from Boehringer Mannheim.
IL-8 rabbit anti-human polyclonal capture antibody was from AMS (Oxon, UK),
alternatively, a murine hybridoma-derived IL-8 monoclonal capture antibody was
obtained from R&D Systems (Oxon, UK), goat anti-human polyclonal detection IL-8
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antibody was from R&D Systems (Oxon, UK). Concentrations were determined by
cross-titrations.
ILip and TGFp ELISA kits obtained from R&D Systems.
2.2.13b) Standards
Recombinant human IL-8 (endothelial cell derived) and recombinant human TNFa
were obtained from R&D Systems.









Na2C03/NaHC03, pH 9.6, carbonate
bicarbonate capsules (Sigma)
1% Bovine serum albumin (Fraction V,
Sigma) in coating buffer
Tris-HCl (20mM)/NaCl (150mM), pH
7.4 Tween 20 (0.1%)
Tris-HCl (20mM), pH 7.4, NaCl
(150mM) 1%BSA
Sodium acetate-citrate lOOmM pH 4.9
TMB (3,3',5,5'-Tetramethylbenzidine)
dissolved in DMSO (dimethylsulfoxide)
lOmg/ml
1 OOpil TMB stock solution in 10ml





High binding flat bottom 96 well plates (Coming Costar, High Wycombe, Bucks.)
were coated overnight at 4°C with the capture IL-8 antibody diluted in coating buffer,
then blocked in coating buffer with 1%BSA. After each step, unless otherwise
stated, washing with TBS-Tween 20 (4 x 200pl/well) was performed. Standards
(20ng-0.02ng) and samples were then diluted in TBS 1%BSA and incubated at 4°C
overnight (16 hours). The detection antibody was added and incubated for 2 hours at
room temperature. Rabbit anti-goat IgG-peroxidase conjugate (100pl/well, Sigma)
was then incubated for 2 hours at room temperature, this was followed by the
addition of substrate solution (TMB in sodium acetate citrate with H202,
1 OOpl/well). The colour was allowed to develop protected from light, and stopped
with lOOpl H2S04/well. The optical density was measured with a plate reader
(Dynatech MR5000, Billinghusrt, Kent) at 450nm with a correction filter at 630nm.
2.2.14b) TNFa ELISA
High binding flat bottom 96 well plates (Coming Costar, High Wycombe, Bucks.)
were coated with capture anti-TNFa in coating buffer, at 35°C for 2hr then blocked
in blocking buffer. Samples were diluted 1:5 in sample buffer and were incubated
with standards overnight at 4°C. The detection antibody was incubated for 4hr at
room temperature. Substrate reaction and optical density were performed as
described in section 2.2.14a.
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2.2.14c) TGFp ELISA
ELISA kit manufacturers protocol was followed. Prior to assaying, samples for
TGFp ELISA were acid-activated to activate latent TGFp to the immunoreactive
form. To lOOpl cell culture supernatant 20pi IN HC1 was added, vortexed and
incubated for 10 minutes. This was then neutralised by adding 20pl 1.2N
NaOH/0.5M HEPES and vortexing. All incubation steps were performed at room
temperature. Samples were then incubated in the pre-coated anti-TGFp
immunoassay plates provided, for 3 hours. After washing, HRP-conjugated anti-
TGFp was added to each well. After 1.5 hours, the plates were washed, then
incubated with substrate solution. The substrate reaction was stopped with 1M
H2S04, and read as described in section 2.2.14a.
2.2.14d) IL-ip ELISA
The manufacturer's protocol was followed, all incubation steps were performed at
room temperature. Briefly, samples were diluted (1:5) and incubated in the pre-
coated anti IL-1 immunoassay plates provided, for 2 hours. After washing, HRP-
conjugated anti-IL-1 was added to each well. After 1 hour, the plates were washed,
then incubated with substrate solution. The substrate reaction was stopped with 1M
H2S04, and read as described in section 2.2.14a.
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2.2.14e) Hyaluronan Competitive ELISA
High binding flat bottom 96 well plates (Corning Costar, High Wycombe, Bucks.)
were coated overnight at room temperature, with hyaluronan 25pg/ml in coating
buffer. Plates were then washed in PBS-Tween (4 x 200p,l/well) and blocked with
1%BSA in PBS-Tween for 1 hour at room temperature. Samples (BAL fluid was not
pre-diluted), standards and biotinylated hyaluronan binding region (kindly provided
by Mike Bayliss) diluted in PBS 1%BSA were added together, and incubated
overnight at 4°C. After washing in PBS-Tween (4 x 200pl/well), streptavidin-
biotinylated HRP complex was added and incubated at 37°C for 30 minutes. The
substrate used was either 2,2'-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid)
(ABTS) in 0.1M citric acid pH 4.0, which was read at 405nm (Fosang et al., 1990),
or TMB read at 450nm.
2.2.14f) Calculation of ELISA results
Optical densities for standards, blank wells, and samples were manually entered onto
an Apple Macintosh computer and analysed using Assay Zap (Biosoft, Cambridge)
software.
2.2.15 Molecular Biology
All reaction steps and reagents were carried out or stored on ice unless otherwise
stated.
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In order to prevent RNase contamination reagents and pipettes were set aside
specifically for RNA work. Sterile disposable plastic ware was used which did not
require pre-treatment to inactivate RNases. The laboratory area used was first treated
with RNase away (Molecular Bio-Products Inc., San Diego, USA) and disposable
gloves were changed frequently.
2.2.15a) RNA extraction
Cells for RNA extraction were either plated onto 6 well tissue culture grade plastic ±
lpg/ml LPS or onto 6 well tissue culture plates pre-coated with hyaluronan (lmg/ml)
in monofeed at a cell density of 106/ml.
Prior to cell lysis, cell culture supernatant was removed, and 3ml lysis buffer (Trizol,
Life Technologies, Paisley, UK) was added to the monolayer, DNA was sheared by
vigorous pipetting. Cell homogenates were incubated for 5 minutes at room
temperature to allow the complete dissociation of nucleoprotein complexes. To these
samples, 600pl was added, and following a brief shake (by hand), samples were
incubated at room temperature for 2 minutes, then centrifuged at 12000 x g for 15
minutes. Following centrifugation two phases were clearly visible. The upper phase
was transferred to a sterile RNase-free micro-centrifuge tube, ensuring the interface
layer was not disturbed. The lower layer and interface, containing phenol, proteins
and DNA was discarded.
51
2.2.15b) RNA Precipitation
RNA was precipitated with 1.5ml isopropanol, after 10 minutes incubation at room
temperature, samples were centrifuged at 12000 x g for 10 minutes. The supernatant
was then carefully aspirated, and the RNA pellet was washed once with 2ml 75%
ethanol. After centrifuging (7500 x g) for 5 minutes, the pellet was allowed to dry,
then re-dissolved in 8pl RNase-free water.
2.2.15c) DNase treatment
Purified RNA was treated with RNase free DNase (lOpg/ml, Gibco) to degrade any
contaminating DNA. DNase buffer (lpl lOx buffer) was added to the re-dissolved
RNA pellet (8pl), with 0.5pl DNasel (lOpg/ml) and 0.5pl placental RNase inhibitor
(Life technologies). The RNA was incubated at 37°C for 15 minutes then at 90°C
for 10 minutes to inactivate the DNase enzyme.
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2.2.15d) cDNA synthesis
DNase treated RNA (lOp.1) was incubated with reagents described in table 2.3, to
give a final volume of 20gil. All PCR reagents were from Life Technologies except
dNTPs, which were from Pharmacia Biotechnology (St. Albans, Herts.)
Table 2.3 Reagents for cDNA synthesis
Reagents Volume (p.1)
First Strand Buffer(5 X) 4.0
DTT(lOOmM) 2.0
Oligo DT (lmg/ml) 1.0
RNase Guard (lU/pl) 1.0
MLV-RT (200U/pl) 1.0
dNTP(lOmM) 1.0
This first strand mix was pipetted thoroughly then incubated at 37°C for 60 minutes
to allow synthesis of cDNA from RNA, followed by 90°C for 10 minutes, to
inactivate reverse transcriptase.
2.2.15e) PCR
cDNA (2pl) was amplified by PCR, using TNFa primers (Stratagene) in the PCR
mix outlined below (Table 2.4). Two drops of mineral oil was added to prevent
evaporation during the PCR reaction.
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Table 2.4 Reagents for PCR
PCR Reagents Volume(pl)
PCR Buffer* (10 X) 100
dNTP (2mM) 100
Sense Primer (50mM) 20
Antisense Primer (50mM) 20
RNase Free dH20 760
* 500mM KC1, lOOmM Tris-Cl (pH8.4), 25mM MgCl2
Sense primer; 174 CGGGACGTGGAGCTGGCCGAGGAG 197
Antisense primer; 504 CACCAGCTGGTTATCTCTCAGCTC 528
TNFa primers were synthesised, based on published cDNA sequence in Pennica et
al., (1984), and reconstituted in 5mM Tris-HCl, ImM EDTA.
Controls included PCR mix alone and first strand DNA without Taq polymerase
(Life Technologies).
cDNA was also amplified for GAPDH to confirm the presence ofRNA and to
indicate appropriate loading. The sequence for GAPDH cDNA was obtained from the
genebank entry (http://www.ncbi.nih.gov/genebank/query_form.html) and
synthesised by MWG Biotech (Milton Keynes,U.K.).
Sense primer; 5' -CCACCCATGGCAAATTCCATGGCA-3'
Antisense primer; 5'-TCTAGACGGCAGGTCAGGTCAACC-3'
GAPDH primers were based on cDNA sequence in Maier et al., 1990.
PCR reactions comprised 5 minutes at 98°C after which point 1 pi Taq polymerase
was added and the mixture was subject to a 5 minute annealing at 60°C followed by
35 cycles of 1.5 minutes at 72°C, 45 seconds at 94°C, and 45 seconds at 60°C, with a
final extension of 10 minutes at 72°C.
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Amplified PCR products were diluted in loading buffer (10% glycerol, 10% Ficoll,
0.25% bromophenol blue, lOmM EDTA) and visualised by electrophoresis on 1.2%
SeaKem LE Agarose (Flowgen) gels containing 0.5pg/ml ethidium bromide (Sigma),
viewed under ultra-violet transillumination. The expected TNFa product was 355bp




5A4 hybridoma cells (a gift from G. Dougherty, Los Angeles), stored in liquid
nitrogen, were defrosted rapidly (37°C), washed in warm DMEM and resuspended in
DMEM with additives (Penicillin (0.5U/ml), Streptomycin (0.5U/ml), and L-
glutamine (2mM). These were then centrifuged and seeded at 0.3 x 106/ml in
DMEM with additives and 10% foetal calf serum in tissue culture flasks. Cells were
split into two flasks after 3 days and were kept at less than 106 cells/ml by splitting
regularly, until antibody was harvested. To obtain a concentrated antibody
supernatant, cells were allowed to proliferate until the medium was exhausted, at
which time the cell supernatant was removed, centrifuged (225 x g), to remove cell
debris, and stored at -20°C until required.
2.2.16b) 5A4 Purification
5A4 cell culture supernatant was tested for the presence of antibody by flow
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Figure 2.5
5A4 supernatant was tested for the presence of CD44 antibody by using indirect
immunofluorescence on peripheral blood monocytes, and flow cytometric analysis.
Histograms from one representative experiment are shown, illustrating high levels
of CD44 rnAb binding to monocytes.
A; negative control.
B, 5A4 supernatant.
Supernatant was concentrated by placing in 76mm dialysis tubing on a tray with
Aquicide II (Calbiochem, Nottingham), which served as a desiccant, overnight (4°C).
Concentrated 5A4 was then precipitated with an equal volume of saturated
ammonium sulphate (4.1M) pH 7.0, overnight at 4°C. This precipitate was
resuspended in phosphate buffer (pH 8.0) and dialysed against phosphate buffer pH
8.0 overnight at 4°C. Dialysed 5A4 was adjusted to pH 8.0 with 1M Tris,
centrifuged at 895 x g for 15 minutes, and loaded onto a protein-A Sepharose, CL-4B
(Pharmacia, St Albans, Herts.) column. Prior to loading the concentrated 5A4
supernatant, the column was regenerated by running 50ml 0.1M Tris/0.5M NaCl, pH
8.5, followed by 50ml 0.1M sodium acetate/0.5M NaCl, then 100ml 0.1M phosphate
buffer, pH 8.0. After loading, the column was again washed with 0.1M phosphate
buffer (pH 8) and the absorbance of the eluted solution (280nm) was checked using a
spectrophotometer (PU8620, Phillips). When eluted fractions contained no
detectable protein, the column was eluted with 0.1M citrate buffer, pH 6.5. Eluted
fraction were checked for absorbance and the fractions with high absorbances were
pooled and dialysed in PBS overnight at 4°C. Purified 5A4 was stored in aliquots at
approximately lmg/ml at-20°C until required.
2.2.16c) 5A4 Purity
5A4 purity was assessed by SDS-PAGE and western blotting (figure 2.6).
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Table 2.5 SDS PAGE Reagents
9% 9%
Stacking Gel Separating Gel
STK (stacking gel buffer): 0.5M Tris, pH 6.8 2.5ml -
SEP (separating gel buffer): 1.5M Tris,
pH8.8
- 2.5ml
30% Acrylamide/ 0.8% N'N' methylene bis-
acrylamide
3.0ml 3.0ml




10% Ammonium Persulphate 40pf 40pl
dH20 4.4ml 4.4ml
Sample Buffer (10ml stock): 2.5ml STK, 2ml 20% SDS, 5.5ml 50% (v/v) glycerol,
20/j.I bromophenol blue (1% in ethanol).
Gels were poured taking care to avoid bubbles and left to polymerise according to the
above protocol using the Mini Protean II gel apparatus (Biorad, CA). The samples
(in sample buffer) were heated to 95°C for 5 minutes then loaded onto the gel, with
10pl pre-boiled molecular weight markers (Biorad CA) in a separate lane. Proteins
were separated at 30mA constant current for 2 hours (or until dye front reached the
bottom of the gel) using 25mM Tris/192mM glycine 0.1% SDS (pH 8.3) as the
electrophoresis buffer.
Gels were either stained for total protein with 0.25% (w/v) Coomassie Brilliant Blue;
with 10% glacial acetic acid, followed by destaining in 40% methanol/10% glacial
acetic acid, or blotted onto nitro-cellulose membranes (Hybond C, Amersham, UK)
using Mini Protean II Transfer apparatus (Biorad, CA) with transfer buffer (25mM
Tris/192mM glycine/ 20% methanol) for 4 hours at 400mA.











Purified 5A4 was assessed for purity by SDS-PAGE and western blotting. Photographs of
representative A) acrylamide gel showing reduced 5A4 and molecular weight markers. B) blot
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Figure 2.7
Purified 5A4 monoclonal antibody binding to monocytes was assessed by titration. Mean
fluorescence, as determined by flow cytometric analysis, was used to assess saturating
concentrations of binding. Results from one representative experiment. Purified 5A4 was found
to bind optimally at 5% (1:20 dilution).
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2.2.16d) Western Blotting
After transferring proteins onto nitro-cellulose membranes, blots were blocked in
TBS with 0.5% Tween 20 for 1 hour. Blots were then incubated with goat-anti-
mouse HRP (1:1000) for 30 minutes. After washing in TBS with 0.5% Tween 20,
staining was visualised using DAB, 50pg/ml in TBS pH 7.6 with lOpl 30% H202,
this substrate reaction was stopped with water.
2.2.17 Assessment of cell viability and numbers
Cells suspended in either PBS (peripheral blood monocytes and alveolar
macrophages) or in medium (5A4 hybridoma cells) were diluted 1:2 with 0.2%
trypan blue (Sigma) and lOpl was carefully loaded onto a haemocytometer. Cell
viability was assessed through the exclusion of trypan blue, and cell numbers were
assessed by counting 2x16 large squares, which gave a cell number of n x 104/ml.
2.2.18 Statistical analyses
All statistical analyses were performed using Statview for Apple Macintosh. Where
appropriate (normally distributed data) the two-tailed paired Student's T-test was
used. For non-parametric analysis (BAL samples, chapter 5), the Mann Whitney-U




3.1.1 Surface Antigen Expression
Myeloid cells, like other leukocytes, possess cell surface antigens which direct cell to
cell contact and the interactions with soluble pro-inflammatory mediators, functions
that are necessary for immunological homeostasis. Expression of surface antigens
may be altered upon activation or upon maturation. For example, during myeloid cell
differentiation, expression ofCD 14 (receptor for LPS), which is not expressed on
monoblasts (Zeigler-Heitbrock et al., 1993), increases with maturation and is strongly
expressed on monocytes (Goyert et al., 1988). Monocyte-derived tissue macrophages
may maintain CD14 expression e.g., peritoneal macrophages (Andreesen 1990), or
may down-regulate expression e.g., alveolar macrophages (Barbosa et al., 1991).
Surface molecules may thus reflect the state of activation of cells, and serve as a
trigger of inflammatory events.
Altered surface antigen expression in alveolar macrophages has been observed in
lung carcinoma (Barbosa et al., 1991) and in the chronic interstitial lung disease,
pulmonary sarcoidosis (Hoogesteden 1989). More recently altered surface antigen
expression (CD1 la, CD1 lb, and CD1 lc) was shown to be increased in alveolar
macrophages from patients undergoing cardiac surgery (Tsuchida et al., 1997).
Differences in antigen expression may be caused by local factors such as changes in
surrounding cell populations and their activation states (Striz et al., 1993), or by
production of inflammatory mediators (Kasinrerk et al., 1993, Liao and Simon 1994,
Kruger et al., 1996). In fact, cytokine production in sarcoidosis has been linked with
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altered alveolar macrophage expression of surface antigens such as CD 14 (Zheng et
ah, 1995).
3.1.2 Alveolar Macrophage Autofluorescence
The search for markers to identify people at risk ofARDS is intense. However,
alveolar macrophages, which are the main immunocompetent cells in the lung, reside
in a unique environment in which they are exposed to both blood borne mediators
and inhaled immunogens. This exposure to inhaled substances such as tobacco
smoke may contribute to the high autofluorescence observed in alveolar macrophages
(Skold et ah, 1989). Autofluorescence in macrophages from non-smokers may be
caused by the storage of a variety of flavoproteins, and exogenous pigments (Benson
et ah, 1979, Lenhert et ah, 1986) and is induced after excitation by argon lasers (the
most common lasers in flow cytometers) which emit light at a wavelength of 488nm
(Havenith et ah, 1993). The resulting autofluorescence at 541nm and 580nm
(Viksman et ah, 1994) overlaps with the fluorescence emitted by fluorophores such
as fluorescein isothiocyanate and R-phycoerythrin, which emit at 480 to 580nm and
540 to 640nm respectively (Edelson et ah, 1985).
In this chapter, macrophage surface antigen expression was investigated as a possible
indicator of cell activation, particularly in the pathogenesis ofARDS. Methods
employed to overcome the problem of autofluorescence are outlined, during attempts
to surface phenotype alveolar macrophages, obtained by bronchoalveolar lavages




Monocyte differentiation into macrophages is associated with alterations in
morphology; figure 3.1 shows the cell size ofmonocytes compared with figure 3.2
which shows macrophages derived from monocytes cultured for 5 days in vitro.
Monocytes and monocyte-derived macrophages were phenotyped using a
comprehensive panel ofwell-defined monoclonal antibodies, to provide a phenotypic
reference for flow cytometric analysis of macrophages from BAL (figure 3.3).
Upon in vitro maturation the expression of CD1 lb decreased whereas expression of
CD1 la remained relatively high, freshly isolated monocytes expressed high levels of
both CD1 la and CD1 lb.
MHC class II and CD 14 were chosen for preliminary studies of alveolar macrophages
for two reasons. Both molecules are relatively well established macrophage markers
and show regulated expression. The latter suggestion is supported by data in figure




Photomicrograph showing freshly isolated monocytes, photographed using a x 40
objective.
Figure 3.2
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Monocytes and 6 day monocyte-derived macrophages from the same donors were
stained for surface markers by indirect immunofluorescence, and analysed by flow
cytometry. Mean fluorescence intensity is expressed relative to that recorded for
negative controls (n=7).
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3.2.2 Cell bound ELISA
Flow cytometric analysis of alveolar macrophages (particularly from smokers)
revealed high levels of autofluorescence (not shown). I therefore investigated
different methods to overcome this problem. An alternative method to flow
cytometry for quantitation of surface receptor expression was the use of an enzyme-
linked marker in a colorimetric system which was implemented thus avoiding
fluorescence based assessments. This system was first validated with peripheral
blood monocytes. Figure 3.4 shows the optical densities for CD1 la, CD 14, and
MHC Class II, relative to negative controls, compared with relative mean
fluorescence intensity in cells from the same donors. When the substrate reaction ((3-
galactosidase) was performed at room temperature, very low optical densities were
observed (figure 3.4). Although increasing the substrate reaction temperature to
37°C increased optical densities, the observed values did not correlate well with flow
cytometric analysis. One possibility was that surface marker expression was reduced
as a consequence of using adherent cells, when compared with non-adherent cells
used in flow cytometric analysis. To address this possibility, subsequent assays were
performed with cells in suspension (figure 3.4). However, the results obtained from
three experiments with this modification were not reproducible (not shown). In
contrast to flow cytometry, which provides an estimate of the numbers of surface
receptors per cell, the ELISA gives a measure of antibody reactivity for the total cell














KJ ELISA Adherent Cells (22°C)
□ ELISA Adherent cells (37°C)
HH ELISA cells in suspension (37°C)
Figure 3.4
Monocyte cell surface markers expression was quantified using a cell bound ELISA
technique (n=3), and compared with the relative mean fluorescence obtained by
flow cytometric analysis ofmonocytes from the same donors.
Values from cell bound ELISA are represented by the optical density relative to
negative controls (cells incubated with irrelevant IgG, MOPC).
Values from flow cytometric analysis (relative mean fluorescence intensity) are
expressed relative to the recorded negative control (MOPC).
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3.2.3 Quenching Autofluorescence
As an alternative approach, Hallden et al., (1991) described a method using crystal
violet to "quench" intrinsic cellular autofluorescence. Using this quenching method,
I compared flow cytometric determination of levels of CD1 lb, CD1 lc, and CD 14 on
quenched monocytes, and untreated monocytes. Initial experiments suggested that
mean fluorescence intensity was not significantly affected by quenching (figure 3.5a).
I therefore extended the analysis to use alveolar macrophages from normal
volunteers, obtained by bronchoalveolar lavage (BAL). Crystal violet quenching
significantly reduced the fluorescence emitted from alveolar macrophages stained for
CD1 lb, CD1 lc and CD14 (figure 3.5b, p<0.05). Relative fluorescence on alveolar
macrophages for these surface antigens appeared to be lower than the corresponding
values on monocytes (figure 3.5c). However, the results obtained using the
quenching method were found to be somewhat variable, which may have been due in
part, to the formation of precipitates in the crystal violet solution. Although heating,































Monocytes (a) and alveolar macrophages (b) were "quenched" with crystal violet
prior to surface phenotyping by flow cytometry. Mean fluorescence intensities,
relative to values obtained with negative control were compared (c), n=3.
69
3.2.4 Tandem Dye Flow Cytometry
To overcome problems with auto fluorescence, an alternative method for phenotyping
alveolar macrophages employing new tandem fluorescent dyes, was assessed. These
dyes consist ofR-phycoerythrin (which can be excited with an argon laser at 488nm)
linked to Cy5, which has a peak emission at 670nm and is thus outside the
autofluorescent range. Using the indirect immunofluorescence technique described
in chapter 2, two such products were tested; Quantum Red (Sigma) and Tricolour
(Bradsure Biologicals). After initial titrations using alveolar macrophages from
normal volunteers the BAL cells from a trauma victim at risk ofARDS were
phenotyped using the two products (figure 3.6). A more complete experiment would
have included the staining ofmonocytes using these two products. However, a
further experiment on trauma patient alveolar macrophages, using a panel of surface
antigens with Tricolour resulted in high fluorescence 1 and 2 (the green and red
channels) but low fluorescence 3 (data not shown). These inconsistencies in










HI Alveolar macrophages (TC)
[i7] Alveolarmacrophages (QR)
Figure 3.6
Cell surface markers on alveolar macrophages taken from a trauma victim at risk of
ARDS were assessed by flow cytometry, using the tandem dyes Tricolour (TC)
and Quantum Red (QR), and were compared with the relative expression of
monocyte-derived macrophages, stained by indirect immunofluorescence.
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3.3 Discussion
Monocyte to macrophage maturation in vitro is characterised by a decrease in
peroxidase activity, an increase in cell size and changes in surface antigen expression
(Johnson et al., 1977). These alterations reflect the different roles myeloid cells play
throughout their differentiation, e.g., CD 16 (FcyRIII, involved in phagocytosis) not
expressed on monoblasts, is weakly expressed on monocytes, and is strongly
expressed on alveolar macrophages and other tissue macrophages (Zeigler-Heitbrock
1993). The induction of CD16 in culture-derived macrophages is thus indicative of
their maturation state. Similarly the decreased expression of CD1 lb, which has
previously been reported as a marker for monocytes and granulocytes (Hogg, 1987)
indicates the in vitro maturation of these cells.
The increased HLA-DR expression noted in monocyte-derived macrophages and in
tissue macrophages (Andreesen et ah, 1990, Krombach et ah, 1996) may reflect the
increased functional requirements within inflammatory sites, i.e., processing and
presentation of antigens, especially within the lung where inhaled immunogens
provide a requirement for immunological competence and co-operation.
Interestingly, expression ofCD14 was down-regulated upon in vitro culture, this
confirms previous studies of cultured monocytes (Kaplan et al., 1982, Zeigler-
Heitbrock et al., 1993) and indicates that monocyte-derived macrophages are
comparable with alveolar macrophages in this respect. However CD 14 expression in
monocytes has also been reported to increase upon in vitro culture (Gessani et al.,
1993, Hopkins et al., 1995, Audran et al., 1996). These differences may be explained
by the presence of serum factors in the culture media, as increased CD 14 expression
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occurred in studies where foetal calf serum was substituted for human serum, and
Hopkins et ah, (1995) showed that the presence of foetal calf serum enhanced LPS-
induced up-regulation of CD14 in alveolar macrophages. Alternatively, the presence
of contaminating LPS may result in the up-regulation of CD 14 expression (Hopkins
et ah, 1995, Landmann et ah, 1996). The presence of contaminating lymphocytes
and associated lymphokine production, may also influence monocyte expression of
CD 14 in vitro, GM-CSF has been shown to decrease CD 14 expression in monocytes
and monocyte-derived macrophages (Kruger et al., 1996).
Increased CD71 (transferrin receptor) expression was also observed during monocyte
culture in vitro, this receptor is involved in the control of iron supply to the cell,
through the binding of the major iron carrier protein, transferrin. The up-regulated
expression of CD71 upon in vitro culture ofmonocytes is well documented (Hirata
1986, Andreesen et al., 1990, Bennet et al., 1992), and is probably associated with
increased bactericidal activities (Johnston 1978, Alford et al., 1991), again
highlighting the altered requirements for expression of surface molecules on
maturation from monocytes to macrophages.
The expression of surface antigens, is quantitatively analysed by the use of flow
cytometry which records the relative expression on thousands of cells. However
autofluorescence seen in alveolar macrophages presents problems for quantitation of
surface receptor expression when using methods that employ the use of fluorescent
markers (Edelson et al., 1985). Although cell bound ELISA represents an alternative
method avoiding fluorescent detection, the absolute cell numbers affect the final
substrate reaction and consequently may give rise to inaccurate results, especially
when non-adherent cells are used.
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An alternative approach is to quench intrinsic autofluorescence through the use of
crystal violet. Results presented in this chapter show significantly decreased
fluorescence following crystal violet treatment in normal alveolar macrophages.
Using this technique, the relative expression of all antigens examined (CD 14,
CD1 la, CD1 lb) was found to be lower than that on monocytes and monocyte-
derived macrophages.
These data are consistent with previous studies which showed that these antigens are
down regulated in alveolar macrophages from normal donors (Barbosa et al., 1991,
Perez-Arellano et al., 1993, Viksman et al., 1994, Prieto et al., 1994). The low levels
of expression of adhesion molecules found in lavage macrophages may reflect the
low adhesive state of cells that are removed from the alveoli. Tsuchida et al., (1997)
showed CD1 la, CD1 lb, and CD1 lc expression was increased on alveolar
macrophages as a result of cardiopulmonary bypass during cardiac surgery. This
increase in adhesion molecule expression may have indicated a primed state in these
cells in vivo, as an increase in production ofTNFa and IL-8 was seen in these
otherwise unstimulated macrophages in vitro. However the up-regulation of these
adhesion molecules was not accompanied by any impairment of lung function.
Analysis of alveolar macrophages from one trauma patient using tandem fluorescent
dyes, suggested low levels of expression ofHLA-DR. Although further analyses of
patient samples would be required to test the possibility that trauma resulted in
reduced expression ofHLA-DR. As alveolar macrophages are in constant contact
with inhaled immunogens a high expression ofMHC class II molecules might be
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expected, in fact high levels of HLA-DR have previously been reported in alveolar
macrophages (Viksman et al., 1994).
Repeated experiments using the tandem dyes Quantum Red and Tricolour resulted in
fluorescence in the green and red channels emitted by the autofluorescence and
phycoerythrin but no visible fluorescence in the third channel, suggesting that Cy5
excitation was either not being emitted, or was emitted but not detected. This lack of
signal in the third channel had previously occurred using Tricolour and a
replacement batch was used in the experiment where fluorescence was detected.
Although it is possible that technical problems may have occurred within the flow
cytometer hardware, the problems associated with the use of these tandem dyes
suggested that the Cy5 conjugate may have been unstable.
The results presented in this chapter confirm that macrophages upon maturation from
monocytes in vitro undergo morphological and phenotypic changes, which can be
easily assessed. These changes, including decreased peroxides activity, and
increased expression of CD 16, CD71, and MHC class II molecules, reflect the
changes in cell function, and show some parallels with tissue macrophages.
Phenotypical analyses of alveolar macrophages, using flow cytometric analysis
(figures 3.5 and 3.6) indicated low levels of surface expression of CD1 la, CD1 lb,
CD 14, HLA-DR and CD71, but methodological problems and the small numbers of
cells recovered from patients at risk ofARDS (as these patients cannot be subjected
to aggressive lavage techniques) hindered the phenotypical analysis of alveolar
macrophages. In addition the frequency of trauma samples decreased significantly
75
with the introduction of car safety features such as the drivers airbag, in addition to




4.1.1 Cellular responses to ECM
Within the tissue microenvironment, ECM composition has an important influence
over various aspects of cell function. During morphogenesis it has been proposed
that the ECM environment provides signals regulating the migration and proliferation
of cells (reviewed by Hynes and Lander 1992). Tissue remodelling, both under
hormonal control (e.g. milk gland formation) and during angiogenesis is also
profoundly influenced by the organisation ofECM components (reviewed in
Roskelley et al., 1995, Gailit and Clark 1994).
The extent to which ECM molecules exert their influences over cell motility and
proliferation is indicated in numerous in vitro studies (Clarke et ah, 1982, Brown et
ah, 1993, Klempe et ah, 1994, Peck and Isacke 1996) (Clarke et ah, 1997, Ohtaka et
ah, 1996, Kubota et ah, 1988, Elstad et ah, 1987, Adamson and Young 1996).
4.1.2 ECM influences in inflammation
During inflammatory responses, leukocyte migration is essential for efficient cell
recruitment in response to inciting stimuli and for effective microbicidal and repair
mechanisms. Extracellular matrix components may exert influences on the initial
stages of cell recruitment as hyaluronan has been shown to mediate rolling in
lymphocytes (DeGrendele et ah, 1996, Clarke 1996).
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It is now clear that cellular responses to cytokines may be altered during
inflammation due to the influences ofECM components present in the inflammatory
milieu (Loike et al., 1995, Xu and Clark 1996). Conversely, cellular responses to
ECM molecules may be modulated by inflammatory cytokines, as many receptors for
ECM molecules are activated or modulated in response to cytokines and chemokines
(Jiang et al., 1992, Lundahl et al., 1996). Cytokines may also influence leukocyte
responses indirectly by modifying the composition ofECM (Pettipher 1986, Wahl et
al., 1990, Maniscalco et al., 1994). In addition, degradative enzymes such as matrix
metalloproteases, may generate peptides with altered chemotactic properties (Doherty
et al., 1990).
Thus, the composition of extracellular matrices can differentially affect the ability of
cells to migrate, proliferate, and become activated. Such wide-ranging responses
provide a sensitive mechanism for regulation during inflammation and repair.
4.1.3 ECM and secretion
As previously discussed (Chapter 1) monocytes and macrophages are effective
secretory cells, and various ECM components have been shown to influence cytokine
production. As adherence has been shown to induce monocyte expression of
cytokines (Haskill et al., 1988), the nature ofmonocyte adherence may be important
in the production of a monocyte pro-inflammatory cytokine profile. Additionally,
changes in ECM composition during inflammation may influence the progression of
inflammatory disease. The possibility ofECM composition affecting monocyte
cytokine production was investigated.
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The ability ofmacrophages to release the cytokines TNFa, IL-ip, IL-8 and TGF(3, in
response to adherence to different ECM substrates was examined. Initial
experiments used alveolar macrophages from bronchoalveolar lavage fluid from both
trauma patients and normal healthy volunteers. However poor cell yields and
variable macrophage viabilities were limiting for mechanistic studies. I therefore
developed a more reliable system using peripheral blood-derived monocytes as a
model for macrophages, which possess many features characteristic ofmacrophages,
including production of cytokines. In comparison with alveolar macrophages, these
cells are more readily purified, with better yields and high viabilities (>50% and 90%
respectively). Considering the well-characterised plasticity ofmonocyte function




4.2.1 ECM Effects on Monocyte Cytokine Release
In order to establish whether different ECM components influenced monocyte
cytokine production, monocytes were adhered to tissue culture plastic coated with
various different ECM molecules hyaluronan (lmg/ml), heparan sulphate (10p.g/ml),
vitronectin (10pg/ml) and fibronectin (10pg/ml). Cell supernatants were removed at
4 hours, 8 hours and 24 hours, and were assayed by ELISA for the presence of pro¬
inflammatory cytokines TNFa, IL-ip, IL-8, and TGF(3. LPS stimulation was used to
demonstrate that monocytes were capable of cytokine production, and monocytes
adherent to plastic alone represented a negative control. The release ofTNFa in
response to these ECM substrates is shown in figure 4.1. Significant TNFa release
occurred on hyaluronan (p=0.032) and in the presence of lpg/ml LPS (p=0.003)
when compared to plastic control at 4 hours, and although TNFa release from
monocytes on hyaluronan decreased with time, levels remained significantly elevated
when compared to plastic alone at both 8 and 24 hours. As there was no significant
release ofTNFa from monocytes adhered to heparan sulphate, vitronectin, or
fibronectin this suggests that the TNFa release from monocytes adhered to
hyaluronan was specific. In contrast to the release of TNFa seen upon adhesion to
hyaluronan, significant release of IL-1 occurred only at 4 hours on hyaluronan when
compared to plastic (p=0.03). LPS induced IL-1 release at both 4 and 8 hours, but





























































Adherence separated monocytes were added to tissue culture plates pre-coated with
different ECM substrates; hyaluronan (lmg/ml), heparan sulphate (lOpg/ml),
vitronectin (lOpg/ml), fibronectin (lOpg/ml), or onto plastic ± ljrg/ml LPS. TNFa
release was assessed by ELISA. Monocytes on hyaluronan release significantly
more TNFa than monocytes on control (plastic) substrate (p < 0.05). LPS also
stimulates cells to release TNFa when compared to plastic (p < 0.05). At these
time points none of the other substrates tested induced significant TNFa release,



















































Monocytes were adhered to different ECM substrates; hyaluronan (lmg/ml),
heparan sulphate (lOpg/ml), vitronectin (lOpg/ml), fibronectin (lOpg/ml), or onto
plastic ± lpg/ml LPS. IL-1(3 release was measured by ELISA. Monocytes
stimulated with LPS, or adherent to hyaluronan release significantly more 1L-1 (5
than monocytes on control (plastic) substrate (p < 0.05) at 4 hours, n=4. Error













































Effect of different ECM substrates on the release of IL-8 from adherence separated
monocytes (n=4), IL-8 was assessed by ELISA. At the times investigated there
were no significant differences in IL-8 release from monocytes on different
substrates. Error bars represent standard error of the mean (SEM), where not







































Effect of different ECM substrates on the release ofTGFp from adherence
separated monocytes (n=4), TGFp was assessed by ELISA. At the times
investigated there were no significant differences in TGFp release from monocytes
on different substrates.
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Neither IL-8 release (figure 4.3) nor TGFp release (figure 4.4) were increased
significantly by these ECM molecules or LPS at the given time points studied here.
4.2.2 LPS Neutralising Experiments
Since hyaluronan was not available as an endotoxin-free tissue culture grade reagent
from any supplier, and the size of the molecule precluded use of the standard assay
for the presence of LPS contamination (Limulus assay) a series of experiments were
performed to eliminate the possibility that LPS contamination of hyaluronan
preparations contributed to the observed effects. An antibody to LPS (WN1, kindly
provided by Robin Barclay, S.E. Scotland Regional Blood Transfusion Centre, Royal
Infirmary, Edinburgh.) was obtained which binds to several forms of LPS (Di Padova
et al., 1993). Preliminary experiments pre-incubating WN1 at different
concentrations with LPS (figure 4.5) prior to a 4 hour incubation with monocytes
showed that WN1 did not inhibit the LPS-induced TNFa release in monocytes.
Further experiments using monocyte-derived macrophages and WN1 also failed to
inhibit LPS stimulation (data not shown). An alternative method was therefore
pursued for assessing the contribution of LPS to TNFa release induced by
hyaluronan.
Polymyxin-B (PXB) is an antibiotic that binds to the lipid A moiety of LPS,
abrogating its activity (Morrison and Jacobs 1976). As PXB binds stochiometrically
to LPS (3.5pg/ml PXB binds approximately lOpg/ml LPS) 4pg/ml was considered
adequate. Pre-incubation of PXB at 4pg/ml and 0.4pg/ml with lpg/ml LPS reduced
TNFa release significantly (figure 4.6, p<0.05), but PXB did not affect hyaluronan

















































Figure 4.5 Pre-incubation of different concentrations of WN1 with LPS (1 ug/ml) for 15
minutes did not inhibit the stimulatory effect of LPS on TNFa release (n =1, mean of triplicates:
standard deviation). Incubation of WN1 alone with monocytes had no effect on TNFa release.
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Figure 4.6 LPS (1 pg/ml), tissue culture plates pre-coalcd with hyaluronan (HA) (1mg/ml),
and PMA (1 iiM) were prc-treatcd with polymyxin B (PXB; 0.4ug/ml and 4.0ug/ml). Day 6
macrophages were then incubated for 4 hours under these conditions and TNFa was assessed by
ELISA. PXB significantly reduced LPS-inducedTNFa release (p<0.05) at both 0.4ug/ml (n=9,
mean ± SEM) and 4.(hig/ml (n=7). PXB had no significant effect on HA- or on PMA-induccd
TNFa release.
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PXB is also a known inhibitor of protein kinase-C (PKC), (Mazzei et al., 1982, Aida
et al., 1990) which has a pivotal role in intracellular signal transduction pathways.
Direct activation ofPKC dependent pathways for TNFa production using phorbol
myristate acetate (PMA) (Nishizuka 1984) could not be inhibited (figure 4.6), even at
high concentrations ofPXB. This suggests that PXB does not exert its effect by
inhibition ofPKC activity in this system. Together these data show that the TNFa
release seen following adhesion ofmonocytes to hyaluronan is not due to trace
contamination of hyaluronan preparations by LPS.
4.2.3 Quantitation of TNFa Release in Response to Hyaluronan
To assess whether TNFa production by adherent monocytes was influenced by
hyaluronan in a concentration dependent manner, hyaluronan was pre-coated at
different concentrations onto tissue culture plastic. Monocyte release ofTNFa was
found to increase in parallel with increased pre-coated concentration of hyaluronan
(figure 4.7). I therefore determined the amount of hyaluronan bound to tissue culture
plastic at different concentrations using biotinylated hyaluronan binding region
(HaBR) which binds to the proteoglycan G1 domain (Fosang et al., 1990). Data
shown in figure 4.8 indicate that hyaluronan concentrations above lmg/ml did not
increase optical density values, suggesting that hyaluronan binding may be maximal
at lmg/ml. However, given that monocyte TNFa release is augmented further at
4mg/ml pre-coated hyaluronan, it is possible that HaBR (1 p.g/ml) was limiting
hyaluronan detection at lmg/ml. Titration of HaBR against hyaluronan at lmg/ml
was found to be optimal at lpg/ml (figure 4.9).
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HYALURONAN [mg/m 1 ]
Figure 4.7
Monocytes were incubated for 4 hours on tissue culture plates pre-coated with
increasing concentrations of hyaluronan (sonicated prior to use). Hyaluronan
induced TNFa release in a dose dependent manner. Mean of 5 experiments ±











Assessment of hyaluronan bound to tissue culture plastic with hyaluronan binding
region (biotinylated proteoglycan G1 domain; 1 ug/ml). Hyaluronan binding





Biotinylated hyaluronan binding region (HaBR) was titrated against Img/ml
hyaluronan tissue culture plastic. HaBR detection of hyaluronan appears to plateau
at lmg/ml. Results taken from one representative experiment OD1 and OD2
represent duplicate wells.
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Compared to the other ECM molecules assessed in the initial cytokine release
experiments, lmg/ml hyaluronan may appear to be an excessively high concentration.
However, the concentration used in this study is within the range used in other
studies of the biological effects of hyaluronan. As all hyaluronan preparations were
sonicated prior to use, the biological effects of hyaluronan in terms ofmolecular
weight, in this study would also be supported by other studies.
Investigation of the effect of high ECM coating concentrations (figure 4.10, n=4)
revealed that even when used at very high coating concentrations (5 times those used
in most studies of the effects ofECM components) fibronectin and collagen still
failed to induce significant TNFa release, supporting the suggestion that hyaluronan-
induced effects are specific.
4.2.4 TNFa Protein Synthesis in Response to Hyaluronan
To further analyse the molecular mechanisms involved in hyaluronan induced TNFa
release, the ability ofmonocytes to release TNFa when adhered to hyaluronan over 4
hours in the presence of the protein synthesis inhibitor cycloheximide was
investigated. Pre-treatment ofmonocytes with 50mM cycloheximide for 30 minutes
was sufficient to reduce hyaluronan-induced TNFa release by 75% reaching
significance for both LPS- and hyaluronan-stimulated cells (figure 4.11, p<0.01,
n=4). Consistent with a requirement for new protein synthesis in the release of
TNFa by hyaluronan-adherent monocytes, TNFa mRNA was detected by RT-PCR.
Detailed temporal analysis revealed that TNFa mRNA was transiently expressed
after 2 hours ofmonocyte adhesion to hyaluronan, (figure 4.12a), PCR for GAPDH
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indicated that all the samples contained RNA (figure 4.12b). In contrast, TNFa
protein release was barely detectable at 2 hours (at the lower detection limit of the
ELISA) but increased significantly at 4 hours. Together these data indicate that in





































Monocytes were incubated for 4 hours on tissue culture plastic pre-coated with
increasing concentrations of fibronectin and collagen. No significant increase in








HI + CHX [25mM]




Monocytes were either pre-treated with 50liM cycloheximide (CHX), or pre-
incubated in medium alone, for 30 minutes. Cells were then incubated for 4 hours
on plastic, hyaluronan-coated plastic (1mg/ml), or with LPS (1 ug/ml).
Cycloheximide in pre-treated cells was diluted to a final concentration of 25pM for
the 4 hour incubation period. Both hyaluronan- and LPS-induced TNFa release
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Figure 4.12
A. Monocytes were allowed to adhere to tissue culture plastic pre-coated with
hyaluronan for 30 minutes (lane 4), 1 hour (lane 5), 2 hours (lane 6), and 4 hours
(lane 7). RNA was extracted and amplified for TNFa mRNA by RT-PCR. Lane 8
shows the positive control (phytohemagglutinin-stimulated peripheral blood
lymphocytes). Lanes 1-3 represent negative controls. TNFa message is clearly
visible at 2 hours (lane 6)
B. Positive controls (GAPDH) for the same samples were run on another gel,
visible bands correspond to lanes 4-8 in (A).
Both gels were run with lkb DNA ladders for reference.
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4.3 Discussion
Several studies have indicated that monocytes incubated with LPS produce cytokines
(Beutler and Cerami 1986, Morrison and Ryan 1987). LPS was used in this system
as a positive control. Data presented in this thesis confirm monocyte release of
TNFa and IL-ip (Matthews 1981, Mayernik 1984) in response to LPS. However,
neither IL-8 nor TGFp release appeared to be affected by LPS treatment of adherence
separated monocytes.
IL-8 is constitutively released by adherent monocytes (Kasahara et al., 1991),
published levels have ranged from lOng/ml (Dentener et al., 1993, 1993a), to
32ng/ml (Hallsworth et al., 1994). IL-8 release in monocytes has also previously
been shown to be enhanced in response to LPS (Peveri et al., 1988) and reported
levels range from lOOng/ml (Heinel et al., 1995) to 400ng/ml (Dentener et al., 1993).
These differences in IL-8 release upon stimulation with LPS may reflect different cell
isolation procedures; the studies showing a significant release with LPS used
monocytes isolated from buffy coat preparations. It is possible that the buffy coat
monocytes were primed prior to stimulation with LPS whereas those studies where
no significant increase in release was seen (including my own) used freshly isolated
monocytes from peripheral blood. Alternatively, discrepancies in reported levels
may be explained by a recent WHO collaborative study (Mire-Sluis et al., 1997)
which indicates much inter-laboratory variation of IL-8 assays, which could result in
a 5-10 fold difference in IL-8 estimates for the same sample in different laboratories.
So although absolute values for IL-8 release may be questionable, the relative release
is of course a useful indicator of the cell activation state.
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LPS also failed to increase TGFp release in my experiments. Although TGFp
mRNA was found to be constitutively expressed in monocytes and macrophages
(Assoian et ah, 1987) and monocytes isolated from the synovial fluid of patient with
rheumatoid arthritis secreted active TGFp, peripheral blood monocytes released only
small amounts (1.4ng/ml) of latent TGFp (Wahl et ah, 1990). This level is
comparable to the constitutive TGFp release seen in my experiments. However, both
Assoian et ah, (1987) and Wahl et ah, (1990) found that LPS (at 10pg/ml and lpg/ml
respectively) increased TGFp release over 24-48 hours. It is likely that lpg/ml over
the shorter time periods in my experiments (4 and 24 hours) was not sufficient to
significantly enhance TGFp release.
Monocyte adherence to fibronectin, vitronectin, and heparan sulphate did not result
in any significant cytokine release in this system. Fibronectin has previously been
shown to stimulate monocytes and macrophages to release TNFa (Beezhold and
Personius 1992, Peat et ah, 1995), and IL-ip (Graves and Roman 1996), however
these studies investigated the effects of exogenous fibronectin added in solution to
cells adherent to plastic. Although adherence to plastic alone may be sufficient to
induce IL-8 release (Kasahara et ah, 1991) and to induce the expression ofmRNA for
CSF-1 and TNFa (Haskill et al., 1988, Eierman et al., 1989), Haskill et ah, (1988)
found that a second stimulus (LPS) was necessary for the translation and secretion of
TNFa and CSF-1. Previously vitronectin has been shown to enhance TNFa
production in macrophages when bound to beta-glucan (Olson et al., 1996), i.e.,
when acting in concert with another stimulus. It is possible that in studies in which
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soluble fibronectin triggers TNFoc production, the monocytes are primed by the
adhesion to plastic and the fibronectin is acting as a second stimulus. This
suggestion could also explain the lack of cytokine induction in response to monocyte
adherence to vitronectin, seen in my studies.
In contrast to the other ECM substrates investigated, notably the structurally related
glycosaminoglycan heparan sulphate, adherence to hyaluronan resulted in a release of
TNFa, which was dose dependent. Over longer times (24 hours) the TNFa release
decreased, this may have been due to a toxic effect of hyaluronan on monocytes
(discussed in chapter 5). Monocyte sequestration and internalisation ofTNFa has
not been reported, but remains as a possible explanation for reduced levels of TNFa
production at longer time points. Alternatively hyaluronan may have been degraded
by monocytes, thereby neutralising its pro-inflammatory effect. Although
macrophages have been implicated in the uptake and degradation of hyaluronan
(Underhill et al., 1993), it is unlikely that this occurs in monocytes (see chapter 5).
However, this possibility could be addressed by assessing the hyaluronan present on
the tissue culture plastic after removing the monocyte monolayer. Longer time points
may also be complicated by monocyte production and deposition ofmatrix proteins.
The extent to which this occurs could be ascertained through the use ofECM-binding
proteins, or antibodies, after the removal of the monocyte monolayer. These
complications may be minimised by considering data from shorter time points.
Although hyaluronan-induced TNFa release increased with hyaluronan
concentration, hyaluronan binding to tissue culture plastic was found to plateau at
lmg/ml, detected with hyaluronan binding region (HaBR). It is possible that
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assessment of binding was limited by the HaBR concentration, but considering the
detection limits of such a colorimetric assay it is unlikely that increased concentration
ofHaBR would generate a higher optical density. At higher concentrations the
viscosity of hyaluronan may influence immunomodulatory actions. At
concentrations of above lmg/ml, molecular entanglement occurs in hyaluronan
solutions (Ogsten and Stanier 1953) which tend to form a continuous network and
therefore affect physical interactions with cells, below lmg/ml hyaluronan molecules
remain separate (Laurent et al., 1960).
Adhesion to hyaluronan was sufficient to induce both TNFa mRNA at 2 hours, and
significant secreted TNFa and IL-1P protein at 4 hours. Although TNFa mRNA is
also transiently induced by LPS, and has been found to peak at 2 hours post-
stimulation (Kohn 1992, Donnelly et al., 1995), LPS contamination was excluded in
my system by experiments in which the effects of polymyxin-B were assessed.
Polymyxin-B inactivates LPS activity (Morrison and Jacobs 1976) and did not affect
the hyaluronan-induced TNFa release.
Polymyxin-B has also been shown to inhibit PKC activity (Mazzei et al., 1982, Aida
et al., 1990), which is one pathway by which LPS activation can occur (reviewed by
Sweet and Hume 1996). In fact experiments using PMA, which directly activates
monocytes through a PKC-dependent pathway, indicated that the concentration of
polymyxin-B was not sufficient to inhibit PMA induced PKC activation. Thus it is
likely that the marked reduction in LPS-induced TNFa release was due to the
specific interaction between polymyxin-B and the lipid A portion of LPS, and not
through the inhibition ofPKC activity.
98
TNFa mRNA expression has been reported in murine macrophages in response to
soluble hyaluronan (Noble et al., 1993). Expression ofTNFa mRNA was induced at
1 hour following stimulation with lmg/ml soluble hyaluronan and was sustained for
12 hours. The difference in mRNA expression over time in human monocytes may
reflect species differences, although this difference was not investigated. TNFa
release from human monocytes was also induced in response to soluble hyaluronan
(see chapter 5). It is interesting that the kinetics of hyaluronan-induced TNFa
mRNA expression differs from that of adherence to plastic which has been reported
to induce TNFa mRNA transiently after as little as 20 minutes (Haskill et al., 1988).
In contrast Eierman et al. (1989) found sustained expression from 40 minutes over 12
hours. However, Eierman et al., used monocytes from platelet pheresis bags (buffy
coats) which again may have influenced the cell activation state.
The hyaluronan-induced production and release ofTNFa and IL-1 in human
monocytes is supported by previous studies in other species. Soluble hyaluronan has
previously been shown to stimulate IL-1-like activity in rabbit peritoneal
macrophages and human monocytes (Hiro et al., 1986). More recently, hyaluronan
induced mRNA transcripts for TNFa and IL-1 (3, and increased constitutive IGF-1
synthesis in murine bone marrow-derived macrophages (Noble et al., 1993) which
was shown to be dependent on TNFa expression. Interestingly, hyaluronan has also
been shown to increase IL-8 mRNA in alveolar macrophages from patients with
idiopathic pulmonary fibrosis (McKee et al., 1996). Although IL-8 mRNA was not
assessed in the present studies, it is possible that, like the TNFa induced IGF-1
release, TNFa may also affect the production of IL-8. TNFa has previously been
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shown to induce IL-8 expression in human astrocytoma cell lines (reviewed in
Chouaib et al., 1991). To address this question TNFa neutralising antibodies could
be incorporated to block any TNFa induced activity. This would be an interesting
experiment to carry out, as it would provide more insight to the network of cytokines
involved in the monocyte/macrophage response to hyaluronan.
Hyaluronan-induced release of TNFa was significantly reduced in the presence of
cycloheximide, in conjunction with this TNFa mRNA data, significant release of
TNFa protein was not detected before 4 hours, indicating that de novo protein
synthesis is required. These data do not preclude cleavage from membrane bound
protein, or intracellular granules as contributory mechanisms for release. To assess
these possibilities fluorescent labelled anti-TNFa antibodies, or intra-cellular staining
of fresh monocytes could be employed, although low levels ofTNFa would be
difficult to detect. Alternatively, inhibitors of TACE could be incorporated which
would prevent cleavage ofmembrane-bound TNFa.
Recent studies indicate the molecular weight of hyaluronan is an important influence
over cell responses. McKee et al., (1996) found that low molecular weight fragments
of hyaluronan (less than 5x105D) were stimulatory for chemokine gene expression
whereas higher molecular weight forms failed to induce gene expression. Although
Hiro et al., (1986) found that low molecular weight hyaluronan from rooster comb
induced less IL-1 from monocytes, the higher weight form, from human umbilical
cord, was estimated at 8x105D, which is smaller than the inactive preparations used
by McKee et al., which were in excess of 106D. The results in this thesis would
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support the pro-inflammatory effects of low molecular weight hyaluronan as all
hyaluronan preparations were sonicated prior to use.
The results presented in this chapter indicate that hyaluronan, in contrast to
fibronectin, vitronectin, collagen, and heparan sulphate, induces monocyte
production and release ofTNFa, and to a lesser extent, the release of IL-1 p. These




5.1.1 Biological Importance of Hyaluronan
The physiological importance of hyaluronan is highlighted by its presence from the
beginning of embryonic development. Hyaluronan is necessary for the migration of
mesenchymal cells into the blastocoel (Fisher and Salrush 1977), and later in
development of the neural crest (reviewed in Erickson and Perris 1993).
High levels of hyaluronan are seen in normal developing murine lungs (Underhill et
al., 1993). As development progresses the ratio of hyaluronan to protein content
decreases and little hyaluronan has been observed in normal adult rat (Nettlebladt
1989) or mouse models (Underhill et ah, 1993).
In compensatory lung growth after resection of rat lungs (Mueller and Thet 1987)
high levels of hyaluronan are also observed, thus supporting a role for hyaluronan in
tissue remodelling.
5.1.2. Hyaluronan and CD44 in Wound Healing
Wound healing shares several features in common with embryonic development,
particularly with respect to ECM turnover (Chapter 1, section 1.9). Hyaluronan is
deposited early in the wound healing process (Bentley 1967, 1968) is a component of
the provisional matrix (Weigel et ah, 1986) and has been shown to accelerate fibrin
clot formation (LeBoeuf et ah, 1986). Many of the biological effects of hyaluronan
are mediated through the cell surface receptor CD44. Fibroblast migration on
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hyaluronan is enhanced by CD44 expression (Peck and Isacke 1996) and fibroblast
migration into a fibrin matrix is inhibited by antibodies to CD44 (Svee et ah, 1996).
In view of the observation that hyaluronan induces the production of pro¬
inflammatory cytokines from monocytes (Chapter 4), its accumulation after injury
may sustain, or enhance the inflammatory response. One of the central hypotheses of
this thesis is that where inflammatory and remodelling processes are not held in
equilibrium, disease pathogenesis may occur. Accumulation of hyaluronan after
injury in adults may paradoxically enhance the inflammatory response, as adhesion to
hyaluronan induces production of pro-inflammatory cytokines from monocytes. The
pulmonary fibrotic disorders sarcoidosis and idiopathic pulmonary fibrosis, are two
examples with unknown aetiology where increases in hyaluronan have previously
been found (Hallgren et ah, 1985, Bjermer 1989) and may reflect this imbalance.
In this chapter, the presence of hyaluronan in lung tissue and bronchoalveolar lavage




5.2.1 Quantitation ofHyaluronan in BAL
The levels of hyaluronan in samples ofBAL fluid from patients at risk ofARDS and
with established ARDS was assessed by competitive ELISA (Fosang et ah, 1990),
and compared with levels found in healthy volunteers (smokers, n=28 and non
smokers, n=8)(figure 5.1). No significant differences in levels of hyaluronan were
noted between smokers and non-smokers from healthy volunteers, thus these values
were taken together as normal controls. Levels of hyaluronan varied widely in each
group; in established ARDS lavage fluid, hyaluronan levels ranged from 8ng/ml to
800ng/ml with a mean value of 179.0 + 56.8, whereas in the at risk group hyaluronan
levels ranged from 0 to 122ng/ml (mean; 21.4 ± 6.1), with a similar range for normal
controls; 0 to 77ng/ml (mean; 22.8 ± 2.8).
When compared using non-parametric statistical analyses (Mann Whitney-U test),
hyaluronan in the ARDS group was significantly higher than the corresponding levels
in the normal control group (p=0.009). Although the numbers of at-risk patients who
progressed to ARDS were low (n=4), there was a trend towards intermediate values
between healthy controls and established ARDS. It is possible that increases in
hyaluronan in BAL fluid could occur early in lung damage in patients who progress
to ARDS and thus be indicative of the disease progression, however further BAL
sample analyses would be required to establish this.
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Figure 5.1
Bronchoalveolar lavage fluid from patients with ARDS (n=17), at risk of
developing ARDS (n=27), and normal volunteers (n=36) was analysed for
hyaluronan by competitive ELISA. Significantly elevated levels of hyaluronan
were found in samples taken from patients with ARDS (p=0.009) compared with
normal controls. There was no significant difference between patients at risk of
ARDS and normal controls.
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5.2.2 Localisation of Hyaluronan in Lung Tissue Sections
To further investigate the relationship between hyaluronan and disease pathogenesis
in the lung, immunohistochemical staining (figure 5.2) of lung sections was
undertaken. This study revealed the extent of hyaluronan present within the alveolar
spaces and interstitium in lung tissue from patients who died from ARDS. This
analysis was extended to localisation of hyaluronan in lung tissue from patients with
sarcoidosis, cryptogenic fibrosing alveolitis, and tissue without evidence of
interstitial lung disease (figure 5.3). The extent of staining in these groups is less
than that in the ARDS tissue, suggesting that hyaluronan is less prominent in these
disease states. Negative controls included slides stained with HaBR that had been
pre-adsorbed to hyaluronan in solid phase (figure 5.3.3).
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Figure 5.2.1
Lung tissue sections were stained for hyaluronan by indirect immunohistochemistry.
A. Photomicrograph of a normal lung tissue section without evidence of interstitial
lung disease, slight staining for hyaluronan is visible around blood vessels (arrows).
B. Photomicrograph of a lung tissue section taken from a patient who died from
ARDS showing thickened alveolar walls and extensive staining for hyaluronan
particularly within the interstitium. (Both photographed using a x 20 objective)
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Figure 5.2.2
Lung tissue sections were stained for hyaluronan by indirect immunohistochemistry.
A. Photomicrograph of a lung tissue section taken from a patient who died from
ARDS showing extensive staining for hyaluronan in the interstitium, and slight
staining is apparent within an alveolar macrophage (arrow). (Photographed using a x
40 objective).




Lung tissue sections were stained for hyaluronan by indirect immunohistochemistry.
A. Photomicrograph of lung tissue section taken from a patient with sarcoidosis
showing slight staining for hyaluronan particularly around peripheral granuloma
tissue.
B. Photomicrograph of sarcoidosis tissue negative control.
(Both photographed using a x 20 objective)
109
Figure 5.3.2
Lung tissue sections were stained for hyaluronan by indirect immunohistochemistry.
A. Photomicrograph of lung tissue section taken from a patient with cryptogenic
fibrosing alveolitis (or idiopathic pulmonary fibrosis) showing slight staining for
hyaluronan within the matrix of fibrotic alveolar walls.
B. Photomicrograph of cryptogenic fibrosing alveolitis tissue negative control.
(Both photographed using a x 20 objective)
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Figure 5.3.3
A. Photomicrograph showing tissue taken from a patient with ARDS, stained for
hyaluronan with HaBR. As previously, extensive staining can be seen.
B. Photomicrograph showing tissue stained with the same concentration ofHaBR
previously adsorbed to hyaluronan in solid phase. This resulted in a marked loss of
staining thus controlling for the possibility of non-specific staining.
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5.2.3 Expression of CD44 in monocytes
As a complementary approach to examining lung tissue in ARDS samples for
hyaluronan, the expression of the principal receptor for hyaluronan, CD44, was
investigated. In particular the expression of variant isoforms of CD44, which have
been associated with cellular migratory potential and the ability to bind to
hyaluronan, were investigated during in vitro culture ofmonocytes.
The expression of CD44 in monocytes was rapidly up-regulated during in vitro
culture (figure 5.4), especially the variant isoforms v3 and vlO (figure 5.5). There
were no significant differences in CD44 expression in cells cultured on hyaluronan-
coated plastic or cells on plastic alone. The differential expression of CD44 isoforms
on monocytes and macrophages raised the possibility that the response of culture-
derived macrophages to hyaluronan may differ from that ofmonocytes (figure 5.6).
5.2.4 Involvement of CD44 in Hyaluronan -induced TNFa release
Both monocytes and macrophages produce TNFa in response to hyaluronan,
although use of the CD44 monoclonal antibody 5A4 revealed possible differences in








Monocyte expression of CD44 was assessed by indirect immunoflourescence and
flow cytometry, using the monoclonal antibody 5A4, which binds all forms of
CD44. Histograms are from one representative experiment of 4 that were
performed.
A: Negative control, B: Freshly isolated monocytes, C: monocytes adherent to












Monocyte expression of CD44 was assessed by indirect immunofluorescence and flow
cytometry, using the monoclonal antibody 7F4, which defines an epitope associated
with hyaluronan-binding (G. Dougherty, personal communication). Histograms are
from one representative experiment of 4 that were performed.
A: Negative control, B: Freshly isolated monocytes, C: monocytes adherent to plastic





Monocyte expression of CD44 was assessed by indirect immunofluorescence and
flow cytometry, using the monoclonal antibody 5A4, which binds all forms of
CD44. Histograms are from one representative experiment of 4 that were
performed.
A: Negative control, B: Freshly isolated monocytes, C: monocytes adherent to
hyaluronan-coated plastic for 4 hours, D: monocytes adherent to hyaluronan-coated






Monoytes after 4 hours
onocytes after 24 hours
Figure 5.5
In vitro culture of monocytes adherent to tissue culture plastic, resulted in up-
regulated expression of CD44, assessed by indirect immunofluorescence and flow
cytometry, particulary the variant isoforms v3 (A), and vlO (B).
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Pre- incubation with 5A4 (final dilution 1:20 from stock solution, see section 2.2.16
and figure 2.7) significantly reduced TNFa production in culture-derived
macrophages but not freshly isolated monocytes.
Experiments with culture-derived macrophages revealed that 5A4 inhibited TNFa
release by 47% whereas another CD44 antibody; 7F4 was unable to reduce this
TNFa release (figure 5.7). Although both 5A4 and 7F4 recognise epitopes on the N-
terminal, ligand-binding region of CD44, the epitope recognised by 7F4 is apparently
not involved in the hyaluronan-mediated TNFa release.
The release ofTNFa was also observed with macrophages adherent to plastic with
exogenous hyaluronan added in solution (figure 5.8) but this was not inhibited with
5A4 (figure 5.9).
5.2.5 Quantitation ofmonocyte adhesion to immobilised Hyaluronan
To try to determine the molecular basis of observed effects of hyaluronan on
monocyte function the adhesion ofmonocytes to hyaluronan was then investigated.
Initially a colorimetric assay was employed using methylene blue (Oliver et al., 1989,
see section 2.2.11). However, differences in the numbers of cells adherent to
different substrates were masked by cells at the edges ofwells remaining adherent
throughout the washing procedures. Although there were visible differences in cells
remaining in the centre of wells after fixation, once the cells were stained and lysed
the optical densities revealed no significant differences between any of the substrates
(data not shown). Subsequent assays were therefore assessed by microscopic
analysis, 4 random fields were counted in each well, avoiding the edges of the wells.
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Initial experiments showed that cells were more adherent to control substrates
(plastic and fibronectin) than hyaluronan, and that this adhesion was dependent on
the presence of divalent cations (figure 5.10). These observations suggested that the














A comparison of hyaluronan-mediated TNFa release in monocytes and in vitro-
derived macrophages, from the same donor, revealed that macrophages release
more TNFa than monocytes, and that this is partially inhibited by the anti-CD44
monoclonal antibody 5A4. Results taken from one representative experiment of 4






Pre-incubation ofmonocyte-derived macrophages with the anti-CD44monoclonal
antibody 5A4 significantly inhibits the release ofTNFa in response to adherence to
hyaluronan-coated tissue culture plastic (p=0.01), 7F4had no significant effect.












Hyaluronan fug rul ]
Figure 5.8
Monocyte-derived macrophages release TNFa in response to hyaluronan in a dose














Monocyte-derived macrophages release TNFa in response to 100pg/ml soluble






















□ + divalent cations
^ - divalent cations
Monocytes were allowed to adhere to hyaluronan (lmg/ml) and fibronectin lOug/ml
coated plastic for 30 minutes at 37°C. In the presence of the divalent cations
calcium and magnesium, some adherence to hyaluronan and fibronectin was
observed. This adhesion was completely inhibited in the absence of calcium and
magnesium (n=5).
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To attempt to investigate non-integrin mediated adhesion an alternative assay was
employed to assess the amount of adhesion to hyaluronan through receptors other
than integrins (figure 5.11). To reduce the possibility of integrin-mediated adhesion,
the assay temperature was reduced from 37°C to 20°C, and 4°C. In an attempt to
overcome cell losses during washing, plates were centrifuged (205 x g for 1 minute)
prior to removal of medium. However these modifications also resulted in very low
cell numbers remaining adherent to hyaluronan, suggesting that immobilised
hyaluronan does not support shear resistant monocyte adhesion.
As monocytes and macrophages release TNFa in response to hyaluronan in solution
and hyaluronan did not mediate firm adhesion in these cells, hyaluronan may be
providing additional regulatory signals, which give rise to functional effects.
5.2.6 Investigation of the Effects of Hyaluronan on Monocyte Apoptosis
This suggestion raised the possibility that other monocyte functions may be affected
by hyaluronan. Since pro-inflammatory cytokine production was induced by
hyaluronan, an effect that required gene transcription, one possibility was that
hyaluronan might influence cell differentiation, or survival. Monocytes, cultured in
the absence of serum in vitro readily undergo apoptosis (Mangan et ah, 1991).
Therefore, in this study, monocytes were cultured in the presence and absence of
serum to compare the rates of apoptosis induced in monocytes cultured on tissue






Monocytes were allowed to adhere to 96 well plates pre-coated with either lOpg/ml
chondroitin sulphate, or lmg/ml hyaluronan at either 4°C (graphs A and C) or at
22°C (graphs B and D). In addition, plates represented by graphs C and D were




Monocyte apoptosis was assessed morphologically through the use ofAcridine
orange and fluorescence microscopy (chapter 2).
Panel A shows typical morphology ofmonocytes in the presence of serum. These
cells are adherent and exhibit the characteristic 'horse-shoe'-shaped nuclei associated
with viable cells.
Panel B shows monocytes undergoing apoptosis in the absence of serum. During
apoptosis chromatin condenses, and apoptotic cells are recognised by the brightly
stained, and rounded nuclei.
Panel C also shows serum-deprived monocytes, some of which have undergone
nuclear extrusion (evanescence), these cells were referred to as 'ghost' cells.
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Rates of apoptosis were assessed using morphological criteria illustrated in figure
5.12, and table 5.1 shows the rates of apoptosis observed under these conditions,
excluding 'ghost' cells (n=4).
Table 5.1 Effect ofHyaluronan on Monocyte Apoptosis
No Serum 10% Serum




4.4 81.8 1.1 94.2
Tissue culture
plastic





5.6 69.5 2.4 91.5
Tissue culture
plastic





3.4 65.4 4.3 86.5
Tissue culture
plastic
3.1 75.3 2.4 97.4
At 8 hours, serum-deprived monocytes cultured in the presence of hyaluronan
showed a lower rate of apoptosis than serum-deprived monocytes cultured on plastic
(4.4% compared with 8.0%). When compared statistically this difference did not
quite reach significance.
Interestingly, cells on hyaluronan in the presence of serum had higher rates of
apoptosis than serum-deprived cells at 40 hours, again this was not statistically
significant.
Microscopic examination of cell morphology revealed marked differences in the
presence and absence of serum. Monocytes adherent to plastic cultured in the
125
presence of serum remained round (figure 5.12, A) whereas those cultured without
serum became stellate (figure 5.13).
These striking morphological differences were not observed in cells cultured on
hyaluronan (not shown).
Figure 5.13
Photomicrograph ofmonocytes cultured on tissue culture plastic, in the absence of
serum, after 40 hours (magnification x 400). Cells were visualised using Acridine
Orange and fluorescence microscopy.
These cells exhibited a high rate of apoptosis compared with cells cultured in the
presence of serum. Interestingly, they displayed a striking stellate appearance, which
was not seen in cells cultured in the presence of serum.
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5.3 Discussion
In this chapter I have investigated the possible role of hyaluronan in inflammatory
processes. My data indicate that hyaluronan is elevated in patients with ARDS
consistent with Hallgren et al., (1989) who reported hyaluronan levels between 31 to
1640 ng/ml. Increased levels of hyaluronan in the lung is associated with a variety of
situations indicating lung injury, including severity ofRDS in premature monkeys
(Juul et al., 1994), and bleomycin induced lung injury in rats (Nettlebladt et al.,
1989). In addition, the association with veino-lymphatic oedema (Drubraix et al.,
1997), and pulmonary oedema in rabbits (Bhattacharya et al., 1989), and rats
(Nettlebladt et al., 1989) highlights the osmotic properties of hyaluronan. As
hyaluronan molecules in solution behave as highly hydrated random coils and the
osmotic pressure increases exponentially with concentration (Comper and Laurent
1978) hyaluronan, like other glycosaminoglycans, provides an excellent physical
buffering system. These properties may also contribute to the oedema seen in
diseases such as ARDS. However, the physiological significance of the presence of
elevated levels ofhyaluronan is not clear. A number of physical factors may
influence hyaluronan levels. For example increased lymph flow in dogs has
previously been shown to reduce lung hyaluronan content (Townsley et al., 1994) and
artificial ventilation increases hydrostatic pressure in the microvasculature, and
within the interstitium (Hallgren 1989). Increased hydrostatic pressure in ARDS
patients, from artificial ventilation, may contribute to the increased hyaluronan in
BAL, by mobilising hyaluronan from interstitial tissues, but does not account for the
accumulation observed within the interstitium.
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The unusual way in which hyaluronan is synthesised may be a contributing factor in
the accumulation seen in ARDS. Unlike other macromolecules which are
synthesised in intracellular compartments, hyaluronan is secreted from the cell
membrane directly into the extracellular space, indicated by the presence of
hyaluronan synthase activity co-precipitated with plasma membrane markers
(Philipson and Schwartz 1984).
However, the cellular source of hyaluronan in the lung has not been determined.
Unlike type I epithelial cells, type II epithelial cells have been shown to produce
various matrix proteins (Rannels et al., 1987, Simon et al., 1993, Maniscalco and
Campbell 1994) and express CD44 (Kasper et al., 1995), but hyaluronan production
in these cells has not been reported, except in foetal type II cells (Sahu et al., 1980,
Skinner et al., 1987). Other cells likely to produce hyaluronan include pulmonary
endothelial cells, and interstitial lung fibroblasts. Although endothelial cells produce
glycosaminoglycan-rich pericellular matrices in response to IL-1 and IFNy
(Montesano et al., 1984), they produce only very small quantities of hyaluronan in
culture (Amanuma and Mitsui 1991).
Hyaluronan was prominent in the alveolar interstitium in ARDS lung sections (figure
5.2), a pattern of hyaluronan accumulation which is also observed in bleomycin
treated rats (Nettlebladt et al., 1989). This tissue distribution of hyaluronan may
implicate the lung fibroblast, as fibroblasts are normally the most numerous cell
within the interstitium and synthesise most of the interstitial ECM components
(Dunsmore and Rannels 1996). Unstimulated lung fibroblasts express modest levels
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of hyaluronan synthase activity, which is increased by TNFa, IL-1 (Sampson et al.,
1996), and TGF(3 (Westergren-Thorsson et al., 1990).
In normal adult lungs, hyaluronan is restricted to the regions surrounding major blood
vessels, bronchi and bronchioles (Underhill et al., 1993). Underhill et al., also noted
that hyaluronan is prominent in the interstitium during lung development and
decreases on maturation along with an increase in macrophage expression of CD44.
As CD44 functions as a receptor for hyaluronan, increased expression in
macrophages may provide a mechanism for the clearance of hyaluronan in the
developing lung through phagocytosis. This proposed mechanism for hyaluronan
clearance is supported by observed intracellular hyaluronan in macrophage vacuoles
in bleomycin-induced lung injury (Nettlebladt et al., 1989). The interaction of
hyaluronan with macrophages through CD44, may also be an important factor in the
pathogenesis of inflammatory disease since CD44 has been implicated in oedema
formation associated with collagen-induced murine arthritis (Mikecz et al., 1995).
In the adult lung relatively high CD44 expression on alveolar macrophages has been
demonstrated (Viksman et al., 1994). Increased expression of variant isoforms has
also been demonstrated in alveolar macrophages (Culty et al., 1994) and may be
associated with terminal differentiation ofmonocytes (Levesque and Haynes 1996). I
have demonstrated that the expression of CD44 on monocytes was increased upon
maturation in vitro, as was the expression of the variant isoforms v3 and vlO, thus
the use of in vitro differentiated monocytes may reflect alveolar macrophage
responses better than freshly isolated monocytes.
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The myelomonocytic cell lines THP-1 and U937 have been shown to alter variant
isoform expression of CD44 in response to cytokines; TNFa preferentially up-
regulated v9 expression, IFNy up-regulated v6, whereas other cytokines (IL-1, IL-4,
TGFp ) had little effect (Mackay et ah, 1994). It is possible that the environment
created by cytokines produced upon adherence, and subsequent maturation of
monocytes, influences the expression ofCD44 and variant isoforms. Data shown in
figures 5.4.1 and 5.4.3 suggest that the extent to which endogenous cytokines affect
monocyte CD44 expression in vitro may not be great. Monocytes cultured on
hyaluronan-coated plastic did not significantly differ in CD44 expression, when
compared with monocytes cultured on plastic alone, despite the differences in
cytokines in the surrounding medium demonstrated in chapter 4.
Variant CD44 isoform expression is associated with metastasis in tumour cells
(Gunthert 1991, Matsumura and Tarin 1992), but the specific functions of variant
isoforms in macrophages remain unknown. It is now well established that a cell
adhesion mechanism involving such abundant and widely distributed molecules as
hyaluronan and CD44 could not be constitutively expressed in an active form if it is
to provide any selectivity of interaction, and that specific activation signals would be
necessary to elicit function at the appropriate times and sites. Interestingly, resident
and elicited peritoneal macrophages have been shown to differ in post-translational
modifications in CD44 isoform expression (Camp et ah, 1991). Camp et al., found
that unlike the CD44 on resident macrophages, the isoform on elicited macrophages
was not associated with the cytoskeleton, which may therefore have implications for
cell motility. Although the specific consequences of variant isoform expression in
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macrophages remains to be determined, increased weak adherence in some cells
expressing specific isoforms would be consistent with the suggested role ofCD44 in
rolling adhesion and motility.
In experiments that aimed to define the nature ofCD44 mediated adhesion using
static adhesion assays, negligible monocyte adhesion to immobilised hyaluronan was
observed. It is therefore probable that CD44 expressed on monocytes is not capable
ofmediating firm adhesion to hyaluronan. Recent studies have shown that CD44 has
been shown to mediate rolling adherence in lymphocytes (DeGrendele et ah, 1996,
Clarke et al., 1996), similar to the loose tethering mediated by selectins. Clarke et
al., observed that the ability of cells to tether decreased with increased shear, which
could account for cell detachment during the washing procedures in static adhesion
assays. As an alternative approach, monocyte adherence to hyaluronan might have
been quantified by using a flow adhesion assay similar to those used by DeGrendele
et al., (1996). Despite the difficulty in quantifying monocyte adhesion to hyaluronan,
the cytokine release experiments presented in chapter 4 clearly demonstrate
significant TNFa release from monocytes on hyaluronan-coated plastic, suggesting
that hyaluronan-mediated firm adhesion is not required to induce cytokine release.
Previous studies have shown that freshly isolated monocytes do not bind soluble
hyaluronan (Culty et al., 1994, Levesque and Haynes 1996). However, following 8-
16 hours in vitro culture, binding of hyaluronan-FITC by monocytes was observed by
Levesque and Haynes, and by 4 days hyaluronan binding had reached comparable
levels to alveolar macrophages (Culty et al., 1994). In both these studies, the levels
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of hyaluronan binding coincided with increased surface expression of CD44,
suggesting that monocyte maturation, which is associated with up-regulation of
CD44 expression, results in altered responses to hyaluronan. Data presented in this
thesis indicate that in vitro cultured monocyte-derived macrophages release TNFa in
response to hyaluronan. In contrast to monocytes, TNFa release could be partially
blocked by pre-treatment with the anti-CD44 mAb 5A4. Interestingly the anti-CD44
mAb 7F4 did not inhibit TNFa release despite the increased levels of expression seen
in monocytes in culture. Although 5A4 has previously been shown to prevent
hyaluronan binding in a murine lymphoma cell line transformed to express CD44,
7F4 did not (Droll et al., 1995). Thus, the inhibition ofTNFa release seen with 5A4
implicates the involvement of an epitope which plays a role in hyaluronan binding in
macrophages and that the epitope recognised by 7F4, although associated with
monocyte maturation, is not involved in hyaluronan binding.
It is possible that antibody-induced cross-linking of CD44, which is expressed at high
levels on the macrophage surface, may act to inhibit hyaluronan-induced TNFa
release. However, cross-linking of CD44 by immobilised anti-CD44 antibody, has
previously been shown to induce TNFa release (Webb et al., 1990) which would
argue against this possibility.
An alternative possibility is that increased CD44 expression on macrophages,
associated with maturation, leads to increased hyaluronan binding through CD44
(shown by Levesque and Haynes 1996) and so anti-CD44 antibody pre-treatment of
macrophages resulted in significant inhibition of hyaluronan-induced TNFa.
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Although up-regulated expression of CD44 has previously been linked with increased
hyaluronan binding, high expression of CD44 does not necessarily confer
hyaluronan-binding activity. In fact recent studies suggest that increased hyaluronan
binding through CD44 is associated with decreased CD44 glycosylation (Katoh et ah,
1995, Sy et al., 1996). It is possible that increased hyaluronan recognition in culture-
derived macrophages reflects a decreased availability of glucose in the culture
medium, which could result in reduced CD44 glycosylation. Reduced glucose
concentrations have recently been shown to restrict CD44 glycosylation in CHO-K1
cells (Zheng et al., 1997), which induced the recognition of hyaluronan in these cells.
Soluble hyaluronan was also found to induce TNFa release in monocyte-derived
macrophages, an effect that was not inhibited by anti CD44 antibody. One possible
explanation for the differential effect of CD44 mAb is that immobilised hyaluronan
is structurally different to hyaluronan in solution (Laurent and Fraser 1992), eliciting
a different type of response. Alternatively, macrophage adhesion to immobilised
hyaluronan, may induce receptor cross-linking, an effect which would be inhibited by
CD44 antibody treatment.
Although contamination of hyaluronan by LPS remains a possibility for experiments
with soluble hyaluronan, Webb et al., (1990) showed that monocytes did not produce
TNFa when added to microtitre plates pre-coated with LPS, at concentrations that
directly induce TNFa release, suggesting that contaminating endotoxin did not bind
to plastic, or was washed off. Furthermore, the possibility that contaminating LPS
has effects in experiments using immobilised hyaluronan seems unlikely, particularly
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in view of the experiments incorporating polymyxin-B discussed in chapter 4.
However, for studies of the effects of soluble hyaluronan it would be important to
include polymyxin-B to address this possibility.
The potential pro-inflammatory effects of hyaluronan on monocyte function raised
the possibility that hyaluronan may influence other aspects ofmonocyte behaviour
that would influence progression of inflammatory responses, including cell survival.
As inflammation is resolved, the number ofmonocytes in the inflammatory site
decreases. It has been shown that in the absence of activation factors, monocytes in
culture undergo apoptosis (Mangan et al., 1991) suggesting that, like neutrophils,
recruited monocytes may undergo programmed cell death and be cleared from the
inflammatory site.
Mangan et al., (1991) also showed that TNFa promoted monocyte survival in the
absence of serum. As hyaluronan induced monocytes to release TNFa (chapter 4) it
may be expected that monocyte survival could be enhanced by hyaluronan in the
absence of serum. However, inhibition ofmonocyte apoptosis requires the
continuous presence of cytokines (Mangan and Wahl 1991), thus any decrease in the
rate of apoptosis through hyaluronan-induced TNFa release in this system would be
expected to be temporary. The difference in apoptosis rates between serum-deprived
monocytes in the presence and absence of hyaluronan was not great. However, it is
conceivable that the presence of TNFa may have contributed to this small change.
Although not statistically significant a small percentage change could be significant
physiologically. Further experiments, perhaps including the use of neutralising
antibodies to TNFa, would be necessary to convincingly demonstrate this.
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Another possibility is that the ligation of hyaluronan through alternative hyaluronan
binding receptors may provide a direct signal for altered cell survival. A number of
observations indicate a role for hyaluronan receptors in providing positive and
negative signals that regulate cell death. Ligation of CD44 with hyaluronan, or
monoclonal antibodies to CD44 has been shown to inhibit T-lymphocyte apoptosis
(Ayroldi et al., 1995). In contrast, a recent study has shown that fibroblast apoptosis
is induced through CD44 ligation (Henke 1996). These differing responses to CD44
ligation in different cell types remain unexplained.
Interestingly, apoptosis in colon cancer cells and T-lymphocytes has previously been
associated with shedding of surface CD44 (Gunthert et al., 1996, Howie et al., 1994),
another illustration of the involvement ofCD44 in cell survival signals. It would be
interesting to observe the survival responses of alveolar macrophages to hyaluronan,
as these cells are noted for their longevity. Indeed, although macrophage apoptosis
has been demonstrated in vitro (Munn et al., 1995, Bingisser et al., 1996), it has not
been observed in vivo. In vivo evidence suggests that macrophages appear to be
removed via the lymphatic system (Bellingan et al., 1996), or via the mucociliary
escalator (Weibel 1984).
The stellate appearance ofmonocytes cultured on plastic in the absence of serum is
also interesting. Neither monocytes on hyaluronan, nor on fibronectin (data not
shown), exhibited this morphology.
Receptors involved in tethering monocytes to different substrates, and the type of
adhesion may in turn influence the cell morphology. Initial adherence to plastic is
thought to be mediated largely by integrins (Buescher et al., 1985, Rosen and Gordon
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1987) and scavenger receptors (Fraser et al., 1993) in a divalent cation dependent
manner, consistent with data shown in figure 5.10. However, in the absence of
serum factors, initial cell spreading may not be maintained and the monocytes may
then de-adhere and retract cytoplasmic extensions, giving rise to a stellate
appearance. This could be tested through the use of time lapse photography which
has previously been used to observe the formation of stellate fibroblasts (BHK21
cells), induced by elevation of cAMP levels. This response occurs through the
outgrowth of processes and is inhibited by the addition of serum (Edwards et al.,
1993). Human serum albumin has been shown to inhibit cAMP production in
mononuclear cells (Fischer et al., 1992), which may suggest that cells cultured in the
absence of serum become stellate through elevated intracellular cAMP levels.
Monocyte maturation into macrophages rather than dendritic-like accessory cells
during in vitro culture may be promoted by serum, which is required to overcome the
effects of cAMP (Najar et al., 1990).
Another possibility is that in the absence of serum factors, monocyte production of
cytokines such as IL-4 might drive monocytes to assume a stellate morphology
characteristic of dendritic cells (Te Velde et al., 1988), this possibility could easily be
tested by ELISA. In addition to conferring a dendritic phenotype in monocytes, IL-4
has been shown to enhance monocyte apoptosis (Mangan et al., 1992) which would
be consistent with the higher apoptosis rates observed in these stellate monocytes.
The data presented in this chapter indicate that hyaluronan, which has been shown to
mediate inflammatory responses in monocytes (chapter 4), also results in macrophage
production of TNFa. The partial inhibition ofmacrophage TNFa release by anti-
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CD44 antibody clearly indicates the involvement ofCD44 in this response. The
increased presence of hyaluronan in BAL from ARDS patients and the extent of
accumulation within the interstitium may indicate a role for hyaluronan mediated




The inflammatory response is initiated as a result of tissue injury, caused by various
stimuli, and leads to vascular changes, leukocyte infiltration and the production of
inflammatory mediators, which act in concert to reduce tissue damage and eliminate
the provoking stimuli. Cells of the monocyte-macrophage lineage play a central role
in inflammation and in the pathogenesis of inflammatory disease states. In addition
to their role in eliminating micro-organisms through effective phagocytic and
cytocidal mechanisms, monocytes and macrophages produce a vast array of
cytokines, growth factors, and chemokines, including TNFa, IL-1, TGFp, and IL-8
which affect the responses of other cells, and influence the progression of
inflammation. In fact, the induction of the inflammatory response is initiated by
cytokines such as TNFa (Tracey and Cerami 1994), without which the repair process
breaks down (Marino et al., 1997).
During extravasation into tissues, peripheral blood monocytes undergo a series of
adhesions and de-adhesions to other cell types, initially vascular endothelium, cells
of the interstitium, and epithelial cells. This process ofmonocyte extravasation also
involves interaction with components of the extracellular matrix (ECM), which are
normally present in the basement membranes around vascular endothelium and, in
the lung, under alveolar epithelial cells. The pulmonary interstitium, which
maintains lung integrity during ventilation, also contains ECM components, such as
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collagen, elastin, and proteoglycans (Weibel and Crystal 1991). Basement membrane
components include proteoglycans such as heparan sulphate (Sannes et al., 1993,
Sivaram et al., 1995), collagen (Madri and Furthmayr 1979), and glycoproteins such
as fibronectin (reviewed by Farhardian et al., 1996). Provisional matrices, which are
present during wound repair and formed through vascular coagulation, may comprise
fibronectin and fibrin (Clark et al., 1982), vitronectin (Grinnel et al., 1992), and
hyaluronan (Weigel 1986). Thus, extracellular matrix components are one of the first
influences on monocytes recruited to sites of injury as they enter tissues.
The aim of this thesis was to characterise the activation of cells of the monocyte-
macrophage lineage in inflammation by examining the relationship between cytokine
production and binding to ECM.
Ideally these studies would have used alveolar macrophages recovered from
bronchoalveolar lavage from patients and healthy volunteers. Although some
experiments presented in chapter 3 used these cells, the culmination of technical
difficulties, including the unreliable recovery of reasonable numbers of viable
alveolar macrophages and problems with autofluorescence, meant that the use of
alveolar macrophages was not practicable. In addition, the frequency of trauma
samples decreased significantly at this time, through the introduction of car safety
features, improved resuscitation methods and more efficient ambulance response
times. As the availability of alveolar macrophages from trauma victims was reduced,
the use of alternative models for alveolar macrophages was therefore explored.
The mouse alveolar macrophage cell line MH-S (Mbawuike and Herscowitz 1989),
the mouse macrophage cell line RAW 264.7, utilised by Noble et al. (1993), or
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murine macrophages derived from bone marrow, or the peritoneal cavity represent
possible models. However, in view of species differences, extrapolation of data from
studies using murine cells to the situation in human disease is difficult. In addition
there may be problems with heterogeneous primary cell populations e.g., peritoneal
macrophages. Models for human alveolar macrophages including monocytes and
"monocyte-like" cell lines U937 and Mono-Mac 6, present different difficulties. For
example, the differentiation ofU937 cells to macrophage-like cells involves their
stimulation with vitamin D3, or PMA which activates PKC (Nishizuki 1984), and
may make interpretation of results more difficult. Although Mono Mac 6 cells have
been reported to represent a more mature monocyte than U937 cells (Zeigler-
Heitbrock et al., 1988, Erl et al., 1995), they retain monocyte characteristics, such as
expression ofmyeloperoxidase (Abrink et al., 1994). In addition, myeloid cell lines
are inherently different from macrophages, as they are actively dividing cells with
altered cell cycle characteristics arising from the original leukaemia, and cell
characteristics can alter if they are not maintained properly.
Monocytes differ from macrophages in many respects, including phagocytic ability,
expression of surface antigens, and their responses to ECM. Thus the use of
monocytes as a model for alveolar macrophages is less than ideal. However, the in
vitro culture ofmonocyte-derived macrophages also presents problems when
assessing the effects of adherence substrates, as monocytes bind avidly to tissue
culture plastic, an activating event which induces the expression and release of
cytokines (Kelley et al., 1987, Haskill et al., 1989, Eierman et al., 1989, Kasahara
1991). In order to avoid adherence activation ofmonocytes counter current
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elutriation was used (chapter 2). As elutriated cells did not survive in culture well,
discontinuous Percoll density gradients were used for the remainder of the project.
Monocyte maturation has been reported to differ in suspension cultures compared
with adherent cells on tissue culture plastic (Triglia et ah, 1985), which together with
difficulty in keeping non-adherent monocytes viable in suspension cultures, limited
experiments with in vitro differentiated macrophages. However, results presented in
chapter 5 were obtained from comparative experiments using suspension cultured
monocyte-derived macrophages. The poor viability of suspension cultured
monocytes may be predicted when considering that in vivo, monocytes survive for
less than 72 hours in the circulation (van Furth and Cohn 1968, Volkman 1970,
Whitelaw and Batho 1972) after which time they enter tissues and differentiate into
macrophages. During extravasation monocytes undergo various types of adherence
(chapter 1) which may provide essential survival signals which delay the induction of
apoptosis. In adherent cultures, the presence of serum has been shown to prevent
apoptosis, however, serum does not improve the viabilities ofmonocytes in
suspension cultures (Mangan 1993).
Although monocyte-derived macrophages may resemble alveolar macrophages in
terms of phenotype more closely than monocytes (chapter 3), human peripheral blood
monocytes were used throughout the project as relatively large numbers could be
obtained comparatively easily. Recent data suggest that large numbers ofmonocytes
are recruited in chronic inflammatory lung disease (Krombach et al., 1996), thus the
data presented in this thesis provides valuable insight to the consequences of cell-
ECM interactions which are likely to occur during inflammatory responses.
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The results presented in this thesis show that hyaluronan, which is a widespread
component of the extracellular matrix, and a major component of the provisional
matrix, has a pro-inflammatory effect on monocytes and monocyte-derived
macrophages. The effects of hyaluronan on monocytes were found to include the
production of cytokines, specifically TNFa and IL-1 p. Evidence presented in chapter
4 argues strongly against the possibility that the pro-inflammatory effect of
hyaluronan was due to contaminating LPS. Furthermore, my data indicated that
adhesion to a variety of other ECM components, including fibronectin, vitronectin,
collagen I and heparan sulphate, which is structurally related to hyaluronan, did not
generate similar effects. Thus the presence of hyaluronan in ECM might exert
regulatory effects on progression of the inflammatory response by invoking pro¬
inflammatory cytokine production.
Receptors involved in the recognition of hyaluronan include RHAMM (the receptor
for hyaluronan-mediated motility) and CD44. RHAMM is expressed at low levels on
many quiescent cells, including macrophages (Turley 1992), and as the name
suggests, is involved in cell motility (Hall et al., 1994). CD44 was first identified as
a lymphocyte homing receptor (Goldstein et al., 1989, Stamenkovic et al., 1989), and
is expressed on both monocytes and macrophages. One interesting finding in these
studies was the difference in responses to hyaluronan between monocytes and
monocyte-derived macrophages. In monocytes, firm adhesion to hyaluronan did not
occur, and the function blocking anti-CD44 antibody 5A4 did not inhibit hyaluronan-
induced TNFa release. This suggests that the mechanism for hyaluronan-induced
TNFa release in monocytes does not involve CD44.
142
Although RHAMM is expressed at low levels on some leukocytes, including
stimulated T-, and B-lymphocytes (reviewed by Hall and Turley 1995), and on
macrophages (Turley 1992) its expression on monocytes has not been reported.
However, the involvement of other hyaluronan receptors has not been precluded.
Interestingly, CD54 (ICAM-1) has been shown to be a receptor for hyaluronan in
hepatic endothelial cells (McCourt et al., 1994). Although CD54 is expressed on
monocytes it remains to be determined if it is involved in monocyte-hyaluronan
interactions. The question ofwhich monocyte receptors mediate hyaluronan effects
could be addressed by using a panel of monoclonal antibodies to monocyte surface
antigens, including CD54. The possibility ofmodulatory effects of CD54 on
monocyte-hyaluronan interactions could also be assessed using soluble CD54.
In contrast to monocytes, the production ofTNFa by monocyte-derived macrophages
in response to hyaluronan was found to involve CD44. Macrophages have previously
been shown to bind hyaluronan through CD44 (Culty 1994, Levesque and Haynes
1996), and results presented in chapter 5 reveal that CD44 expression is up-regulated
during in vitro culture ofmonocytes. Although up-regulated expression ofCD44
associated with maturation has previously been linked with increased hyaluronan
binding, high expression ofCD44 does not necessarily confer hyaluronan-binding
activity. In fact treatment of a T-cell line with PMA has previously been shown to
induce hyaluronan-binding (Lesley et al., 1990), which may implicate the
involvement ofPKC. More recently, U937 cells stimulated with PMA released
TNFa in response to hyaluronan (Boyce et al., 1997), it is therefore possible that
PKC activation promotes the binding of hyaluronan through CD44. Although
polymyxin-B, (which was used to investigate possible LPS contamination) is known
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to inhibit the activation ofPKC (Mazzei et al., 1982, Aida Y et ah, 1990), results in
chapter 4 suggest that PKC was not inhibited by the concentrations used in this study.
The possible involvement of a potential PKC phosphorylation site on the CD44
molecule (Camp et al., 1991) involved in hyaluronan-binding or hyaluronan-
mediated cytokine production in monocytes or macrophages could be confirmed
using specific PKC inhibitors, such as staurosporine.
In addition to effects on cytokine production, data presented in chapter 5 indicate that
hyaluronan regulates survival ofmonocytes cultured in the absence of serum-derived
survival signals. Thus, the hyaluronan-rich provisional matrix may provide
regulatory signals to monocytes entering a site of inflammation, resulting in increased
numbers of inflammatory monocytes present through the inhibition of constitutive
apoptosis signals, and also inducing pro-inflammatory cytokine release.
A number of observations indicate a role for hyaluronan receptors in apoptotic
mechanisms in different cells. Ligation of CD44 has been shown to inhibit T-
lymphocyte apoptosis (Ayroldi et al., 1995), and shedding ofCD44 was associated
with T-lymphocyte apoptosis (Howie 1994), this implies that CD44 plays an
important role in the survival of T-cells. The survival of tumour cells is also affected
by CD44 shedding (Gunthert 1996), and certain tumour cells lose their metastatic
ability when transfected with a construct which produces soluble CD44 (Yu et al.,
1997). Thus, it would appear that CD44 ligation confers survival signals which, in
the case of leukocytes, may result in sustaining inflammatory responses. However,
CD44 ligation may have differential regulatory effects on survival in different cell
types. In fibroblasts, apoptosis is induced through CD44 ligation (Henke 1996), an
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effect which may act to further reduce the production of hyaluronan and other ECM
components.
Other effects of CD44 on macrophages that might affect the progression of
inflammation include the up-regulation of recognition and phagocytosis of apoptotic
neutrophils by monocyte-derived macrophages (Hart et al., 1996) a potential anti¬
inflammatory effect which appears to be independent of hyaluronan binding. In
contrast the results presented in this thesis suggest that hyaluronan may have an
overall pro-inflammatory effect consistent with the inhibition ofmacrophage
phagocytosis by hyaluronan (Suzuki and Yamaguchi 1993).
The observation that patients with ARDS had elevated levels of hyaluronan in BAL
fluid, and prominent staining for hyaluronan in the interstitium (chapter 5), suggests
that excessive deposition of hyaluronan in the lung is indicative of disease. In fact
elevated levels of hyaluronan in BAL fluid have been associated with several lung
disorders: severe asthma (Sahu and Lynn 1978), cystic fibrosis (Sahu 1980),
sarcoidosis (Hallgren et al., 1985), and idiopathic pulmonary fibrosis (also known as
cryptogenic fibrosing alveolitis) (Bjermer 1989). These diseases have different
characteristics and pathologies. Asthma is characterised by widespread airway
obstruction due to inflammation-based changes in airway walls and interstitial matrix
composition (Hogg 1997). The contribution of several cytokines, including TNFa,
have been noted (Barnes et al., 1995). The aetiology of cystic fibrosis is very
different from that of asthma; cystic fibrosis is caused by a genetic defect that affects
the control ofwater and iron transport across epithelial cells (Geddes 1995). The
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effect on the lung is the opportunistic colonisation by bacteria, resulting in a localised
immune response, and inflammation. Sarcoidosis and idiopathic pulmonary fibrosis
are diseases with unknown aetiologies, and very different pathologies. Sarcoidosis is
characterised by the formation of granulomas in the lung (Studdy 1995). These form
through the significant accumulation ofmacrophages and T-lymphocytes, and
cytokines, generated by these cells predominate (James 1997). Progression to a
fibrotic state can also occur (Hallgren et al., 1985). Idiopathic pulmonary fibrosis is
characterised by a slow and progressive fibrosis caused by fibroblast deposition of
matrix and its degradation by neutrophils (Agostini et al., 1997). Alveolar
macrophages contribute to idiopathic pulmonary fibrosis with the production of
cytokines including TNFa and TGFp and are primed for IL-8 production (Nakamura
et al., 1995). Although the underlying pathology and clinical progression of these
diseases are quite different, inflammation is a common feature. In fact increased
hyaluronan has also been associated with lung transplant rejection (Riise 1996)
which represents another inflammatory state of the lung. Thus inflammation must
affect the dynamic nature of ECM in the lung and may therefore affect the deposition
or accumulation of hyaluronan (see figure 6.1).
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Figure 6.1
Possible mechanism for the potential inflammatory role of hyaluronan within the lung.
Macrophage production of pro-inflammatory cytokines, including TNFa and IL-1
results in the production of hyaluronan by endothelial cells. This may facilitate the
recruitment of further inflammatory cells through CD44-mediated rolling, and inhibit
rates of apoptosis in recruited monocytes.
In addition to hyaluronan degradation by hyaluronidase activity in cytokine-stimulated
fibroblasts and neutrophil oxidants, production of low molecular weight hyaluronan is
favoured in fibroblasts by TNFa and IL-1. This low molecular weight hyaluronan
may further stimulate macrophages, thus prolonging or enhancing the inflammatory
response.
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The data presented in this thesis suggest that high levels of hyaluronan in the lung are
associated with disease. However, high levels of hyaluronan are found in the
developing lung (Underhill et al., 1993) and hyaluronan is important in
embryogenesis (Fisher and Salrush 1977, Erickson and Perris 1993). During
embryonic development hyaluronan may, in part, be responsible for specifying sites
of angiogenesis (Banerjee and Toole 1992). Feinberg and Beebe (1983) observed
that blood vessels fail to develop in hyaluronan-enriched tissues in vivo, suggesting
that high concentrations of hyaluronan inhibit angiogenesis, whereas low
concentrations do not (West and Kumar 1989). Hyaluronan deposition may thus
provide a mechanism for the formation of less well vascularised areas optimised for
gas exchange. The presence of high levels of hyaluronan in foetal wound healing is
also thought to facilitate healing without scarring (Longaker et al., 1989, Lorenz and
Adzick 1993, Estes et al., 1993).
The consequences of high levels of hyaluronan in embryonic development and foetal
wound healing would appear to provide an ideal mechanism for wound repair in the
adult lung, where the presence of hyaluronan could facilitate scarless healing and
prevent excessive angiogenesis. Why then, should high levels of hyaluronan have
such a negative association in the mechanism of adult lung repair?
The process of foetal wound healing is regenerative rather than fibrotic, is rarely
accompanied by an inflammatory response (Rowlatt 1979, Longaker et al., 1989a),
and early embryonic wound healing takes place in the absence of macrophages
(Hopkinson-Wooley et al., 1994). In contrast, wound repair in adults often leads to
the formation of scar tissue, initiated by ECM components laid down by wound
fibroblasts, notably a poorly organised collagen matrix (reviewed by Prockop and
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Kivirikko 1995). In cutaneous wound healing this fibrotic response seems
appropriate in order to produce a physical barrier quickly from an often unclean
environment. However, in the lung, this mechanism of repair is inappropriate and
leads to thickening of the interstitium and an impairment of gas exchange interfaces
(Bitterman 1992).
The influences of inflammation and macrophages in adults may also provide answers
to this question. During inflammation, ECM components are often subject to
enzymatic degradation (Wahl and Corcoran 1993, Shapiro 1994), in foetal healing
the degradation of hyaluronan by hyaluronidase (Mast 1992) has been shown to result
in increased collagen deposition, which is more characteristic of adult wound
healing. In an acute inflammatory state such as ARDS degradation ofECM is highly
probable, considering the likely presence of neutrophil proteases and matrix
metalloproteases (Palmgren et al., 1992, Torii et al., 1997). It is probable that unlike
during foetal healing, hyaluronan deposited in an inflammatory environment such as
that seen in ARDS is subject to degradation, either through enzymes, or through
oxidant effects (Baker et ah, 1989, Saari et ah, 1993), and that the degraded
hyaluronan may have a more inflammatory potential than intact hyaluronan. Indeed,
small molecular weight fragments of hyaluronan have been shown to activate murine
macrophages (McKee et ah, 1996, 1997). In fact, the production of low molecular
weight hyaluronan by lung fibroblasts is favoured by the presence of IL-1 and TNFa
due to increased synthase activity, and simultaneous increase in hyaluronan
degradation (Sampson et ah, 1992).
The presence of macrophages in adult lung repair may thus be instrumental in
altering the cellular responses to hyaluronan, especially when considering that the
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expression ofCD44 on macrophages increases during development (Underhill et al.,
1993) and in adults, alveolar macrophages express high levels of CD44 (Culty 1994,
Viksman et al., 1994). Although the underlying mechanism of repair in adults may
thus be similar to those observed in the foetus, altered cellular responses to
hyaluronan in adults may result in a very different outcome.
The work presented in this thesis demonstrates the presence of elevated hyaluronan
levels in inflammatory lung disease (ARDS) and the potential pro-inflammatory
effects of hyaluronan on monocytes and monocyte-derived macrophages, through the
production of pro-inflammatory cytokines and the alteration of apoptotic
mechanisms. The presence of elevated levels of hyaluronan within the pulmonary
inflammatory milieu may therefore alter the relationship between macrophages and
the responses of other cells, and may enhance and sustain inflammation contributing
to the development of disease.
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